Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	Related_Results
	SPEN(40.6%)	exon11,c.3272T>C,p.L1091P	0.406	0.43	23|17	5|3	0.40909	26|18	1	16256007	16256007	T	C	germline,normal_artifact,Germline	SPEN	NM_015001.3	11	c.3272T>C	p.Leu1091Pro	missense_variant	Benign		SPEN-related_condition|Radio-Tartaglia_syndrome		
	SPEN(47.9%)	exon11,c.7078A>G,p.N2360D	0.479	0.268	46|46	12|3	0.46875	51|45	1	16259813	16259813	A	G	germline,normal_artifact,Germline	SPEN	NM_015001.3	11	c.7078A>G	p.Asn2360Asp	missense_variant	Benign		SPEN-related_condition|Radio-Tartaglia_syndrome|not_provided		
	SPEN(23.5%)	exon11,c.8736C>T,p.P2912=	0.235	0.018	330|97	59|0	0.23173	368|111	1	16261471	16261471	C	T	PASS	SPEN	NM_015001.3	11	c.8736C>T	p.Pro2912=	synonymous_variant					
	SPEN(2.3%)	exon11,c.9909T>C,p.F3303=	0.023	0.048	166|4	25|0	0.02151	182|4	1	16262644	16262644	T	C	PASS	SPEN	NM_015001.3	11	c.9909T>C	p.Phe3303=	synonymous_variant					
	CROCC(3.7%)	exon15,c.2039A>G,p.K680R	0.037	0.034	140|5	27|0	0.02415	202|5	1	17272004	17272004	A	G	PASS	CROCC	NM_014675.5	15	c.2039A>G	p.Lys680Arg	missense_variant					
-	ARID1A(13.0%)	exon3,c.1650dup,p.Y551fs	0.13	0.042	81|11	20|0	0.08750	146|14	1	27057936	27057936	G	GC	PASS	ARID1A	NM_006015.6	3	c.1650dup	p.Tyr551fs	frameshift_variant					
-	ARID1A(16.9%)	exon12,c.3216del,p.K1072fs	0.169	0.022	371|68	52|0	0.14922	439|77	1	27097621	27097622	CA	C	PASS	ARID1A	NM_006015.6	12	c.3216del	p.Lys1072fs	frameshift_variant					
-	ARID1A(5.9%)	exon16,c.3991C>T,p.Q1331*	0.059	0.007946	710|43	145|0	0.05308	892|50	1	27100195	27100195	C	T	PASS	ARID1A	NM_006015.6	16	c.3991C>T	p.Gln1331*	stop_gained				COSV61379484	
-	ARID1A(2.9%)	exon20,c.5548del,p.D1850fs	0.029	0.037	250|8	28|0	0.03093	282|9	1	27105930	27105931	TG	T	suspected_bg	ARID1A	NM_006015.6	20	c.5548del	p.Asp1850fs	frameshift_variant					
	WDTC1(20.9%)	exon9,c.868dup,p.E290fs	0.209	0.022	539|152	116|2	0.19843	715|177	1	27621107	27621108	TG	TGG	multiallelic,slippage,distinguished	WDTC1	NM_001276252.2	9	c.868dup	p.Glu290fs	frameshift_variant					
	MUTYH(66.7%)	exon12,c.930G>C,p.Q310H	0.667	0.667	8|18	0|1	0.65517	10|19	1	45797505	45797505	C	G	germline,normal_artifact,Germline	MUTYH	NM_001048174.2	12	c.930G>C	p.Gln310His	missense_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_provided|not_specified|Carcinoma_of_colon|Familial_multiple_polyposis_syndrome|Familial_adenomatous_polyposis_2		
	CDC7(30.6%)	exon2,c.92del,p.N31fs	0.306	0.017	3801|1752	817|17	0.29121	6562|2696	1	91967356	91967358	TAA	TA	clustered_events,multiallelic,distinguished	CDC7	NM_003503.4	2	c.92del	p.Asn31fs	frameshift_variant					
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001111	0.001375	8552|13	1956|2	0.00144	20785|30	1	115252203	115252203	G	A	orientation	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.0008209	0.0009876	8540|8	1956|1	0.00077	20767|16	1	115252204	115252204	C	T	strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant	Uncertain_significance		RASopathy		
1	NRAS(0.1%)	exon3,c.175G>T,p.A59S	0.0009054	0.001765	6094|9	1297|3	0.00161	13055|21	1	115256536	115256536	C	A	orientation,weak_evidence	NRAS	NM_002524.5	3	c.175G>T	p.Ala59Ser	missense_variant				COSV54743482	
	TENT5C(9.5%)	exon2,c.388A>G,p.S130G	0.095	0.012	437|47	86|0	0.09825	514|56	1	118165878	118165878	A	G	PASS	TENT5C	NM_017709.4	2	c.388A>G	p.Ser130Gly	missense_variant					
	HSD3B1(13.9%)	exon4,c.313A>G,p.T105A	0.139	0.072	70|11	18|0	0.13580	70|11	1	120056459	120056459	A	G	PASS	HSD3B1	NM_000862.3	4	c.313A>G	p.Thr105Ala	missense_variant&splice_region_variant					
	SPTA1(43.7%)	exon49,c.6794T>C,p.I2265T	0.437	0.237	22|18	6|1	0.43182	25|19	1	158584091	158584091	A	G	germline,normal_artifact,Germline	SPTA1	NM_003126.4	49	c.6794T>C	p.Ile2265Thr	missense_variant	Benign		not_specified|not_provided|Elliptocytosis_2|Pyropoikilocytosis,_hereditary|Hereditary_spherocytosis_type_3		
	SPTA1(0.9%)	exon6,c.811A>G,p.R271G	0.009122	0.018	873|8	153|1	0.00921	1076|10	1	158648192	158648192	T	C	PASS	SPTA1	NM_003126.4	6	c.811A>G	p.Arg271Gly	missense_variant&splice_region_variant					
	DDR2(1.0%)	exon13,c.1653A>G,p.K551=	0.009764	0.009196	815|9	146|0	0.00969	1022|10	1	162741962	162741962	A	G	PASS	DDR2	NM_006182.4	13	c.1653A>G	p.Lys551=	synonymous_variant					
	PIK3C2B(45.9%)	exon26,c.3594T>C,p.N1198=	0.459	0.333	21|18	5|2	0.47826	24|22	1	204403659	204403659	A	G	germline,normal_artifact,Germline	PIK3C2B	NM_002646.4	26	c.3594T>C	p.Asn1198=	synonymous_variant				COSV65811498	
	IKBKE(3.7%)	exon10,c.1120A>G,p.T374A	0.037	0.078	253|8	28|1	0.02532	308|8	1	206652413	206652413	A	G	normal_artifact	IKBKE	NM_014002.4	10	c.1120A>G	p.Thr374Ala	missense_variant					
	H3-3A(1.3%)	exon3,c.191G>A,p.R64H	0.013	0.018	447|5	67|0	0.00982	504|5	1	226253419	226253419	G	A	suspected_bg	H3-3A	NM_002107.7	3	c.191G>A	p.Arg64His	missense_variant				COSV64733324	
	FMN2(1.8%)	exon5,c.2772_2837del,p.P925_P946del	0.018	0.016	473|11	85|1	0.01299	76|1	1	240370869	240370935	CATACCTCCTCCGCCGCCTCTACCCGGAGCAGGCATACTCCCTCTGCCCCCTCTACCCGGAGCGGGA	C	PASS	FMN2	NM_020066.5	5	c.2772_2837del	p.Pro925_Pro946del	disruptive_inframe_deletion					
	MYCN(1.6%)	exon2,c.134del,p.P45fs	0.016	0.035	1134|18	158|6	0.01536	1538|24	2	16082313	16082314	AC	A	normal_artifact,suspected_bg	MYCN	NM_005378.6	2	c.134del	p.Pro45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Feingold_syndrome_type_1|not_provided		
	ALK(93.7%)	exon1,c.27C>G,p.L9=	0.937	0.5	0|16	0|0	1.00000	0|17	2	30143499	30143499	G	C	germline,Germline	ALK	NM_004304.5	1	c.27C>G	p.Leu9=	synonymous_variant	Benign		not_provided|Hereditary_cancer-predisposing_syndrome|Neuroblastoma,_susceptibility_to,_3|not_specified		
-	MSH2(39.4%)	exon2,c.212-4del	0.394	0.141	530|729	167|37	0.50374	1127|1144	2	47635523	47635526	CTTT	CTT	clustered_events,multiallelic,normal_artifact,distinguished	MSH2	NM_000251.3	2	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|Lynch_syndrome_1		
-	MSH2(8.1%)	exon2,c.212-6_212-4del	0.081	0.014	530|160	167|2	0.14362	1127|189	2	47635523	47635526	CTTT	C	clustered_events,multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-6_212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome		
-	MSH2(19.1%)	exon2,c.212-5_212-4del	0.191	0.016	530|366	167|4	0.32068	1127|532	2	47635523	47635526	CTTT	CT	clustered_events,multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified		
-	MSH2(3.7%)	exon2,c.212-4dup	0.037	0.124	530|75	167|34	0.13241	1127|172	2	47635523	47635526	CTTT	CTTTT	clustered_events,multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided|Hereditary_cancer-predisposing_syndrome		
-	MSH2(1.1%)	exon2,c.212-4T>A	0.011	0.031	2037|31	266|8	0.01569	3324|53	2	47635536	47635536	T	A	clustered_events,normal_artifact,background	MSH2	NM_000251.3	2	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms		
-	MSH6(4.7%)	exon5,c.3261del,p.F1088fs	0.047	0.043	4553|270	948|51	0.04482	7971|374	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Lynch_syndrome_5|Mismatch_repair_cancer_syndrome_3|Lynch_syndrome|Lynch-like_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome|not_provided|Gastric_cancer|Carcinoma_of_colon		
-	MSH6(23.1%)	exon7,c.3557-6_3557-4del	0.231	0.065	30|19	13|0	0.38889	33|21	2	48032740	48032744	ATTTT	AT	multiallelic	MSH6	NM_000179.3	7	c.3557-6_3557-4del		splice_region_variant&intron_variant					
-	MSH6(35.1%)	exon7,c.3557-5_3557-4del	0.351	0.065	30|30	13|0	0.49231	33|32	2	48032740	48032744	ATTTT	ATT	multiallelic	MSH6	NM_000179.3	7	c.3557-5_3557-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_specified		
	XPO1(1.6%)	exon16,c.1724-30_1745del	0.016	0.001843	3282|48	618|0	0.01590	2414|39	2	61719311	61719363	ATCCTGGACTCCATCATGGGTCTCTAACAAGACAAAAATATTCATTTATTTTG	A	PASS	XPO1	NM_003400.4	16	c.1724-30_1745del		splice_acceptor_variant&splice_region_variant&intron_variant&cross_variant					
	RANBP2(1.6%)	exon10,c.1368G>A,p.W456*	0.016	0.023	319|5	47|0	0.01292	382|5	2	109367814	109367814	G	A	PASS	RANBP2	NM_006267.5	10	c.1368G>A	p.Trp456*	stop_gained					
	BMPR2(8.8%)	exon12,c.1748del,p.N583fs	0.088	0.021	3480|361	723|15	0.08276	5475|494	2	203420129	203420130	GA	G	normal_artifact,distinguished	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension|Pulmonary_arterial_hypertension		
1	IDH1(0.1%)	exon4,c.395G>T,p.R132L	0.001051	0.00132	5446|5	1114|3	0.00195	9719|19	2	209113112	209113112	C	A	strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Adenoid_cystic_carcinoma|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Glioblastoma|Neoplasm_of_brain|Breast_neoplasm|Myelodysplastic_syndrome|Malignant_melanoma_of_skin|Multiple_myeloma|Hepatocellular_carcinoma|Acute_myeloid_leukemia|Lung_adenocarcinoma|Medulloblastoma|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder		
	MYL1(33.1%)	exon1,c.-2_1del	0.331	0.004641	914|558	183|0	0.32674	1531|743	2	211179765	211179768	ATTT	A	clustered_events,multiallelic	MYL1	NM_079420.3	1	c.-2_1del		start_lost&conservative_inframe_deletion&cross_variant					
	MYL1(8.9%)	exon1,c.1del,p.M1fs	0.089	0.115	914|151	183|26	0.11809	1531|205	2	211179765	211179768	ATTT	ATT	clustered_events,multiallelic,suspected_bg	MYL1	NM_079420.3	1	c.1del	p.Met1fs	frameshift_variant&start_lost	Benign		MYL1-related_disorder		
	MYL1(2.8%)	exon1,c.1dup,p.M1fs	0.028	0.037	914|55	183|8	0.05727	1531|93	2	211179765	211179768	ATTT	ATTTT	clustered_events,multiallelic,suspected_bg	MYL1	NM_079420.3	1	c.1dup	p.Met1fs	start_retained_variant	Benign		MYL1-related_disorder|not_provided|Congenital_myopathy_with_reduced_type_2_muscle_fibers		
	ERBB4(1.3%)	exon1,c.27C>A,p.V9=	0.013	0.019	738|9	71|0	0.01075	920|10	2	213403228	213403228	G	T	PASS	ERBB4	NM_005235.3	1	c.27C>A	p.Val9=	synonymous_variant					
	BARD1(0.1%)	exon4,c.1109G>A,p.R370H	0.001382	0.0006154	11242|19	3094|1	0.00159	26967|43	2	215645489	215645489	C	T	strand_bias,low_allele_frac	BARD1	NM_000465.4	4	c.1109G>A	p.Arg370His	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(4)|Likely_benign(1)	not_provided|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast		
2	CUL3(2.0%)	exon11,c.1486-2A>G	0.02	0.016	553|10	83|0	0.01479	666|10	2	225365206	225365206	T	C	PASS	CUL3	NM_003590.5	11	c.1486-2A>G		splice_acceptor_variant&intron_variant					
	UGT1A7(0.4%)	exon1,c.364del,p.S122fs	0.004342	0.002707	5140|38	972|3	0.00543	8978|49	2	234590940	234590941	AT	A	low_allele_frac	UGT1A7	NM_019077.3	1	c.364del	p.Ser122fs	frameshift_variant					
	UGT1A1(1.1%)	exon0,c.-55_-54insATAT	0.011	0.009475	3474|78	886|17	0.01399	10997|156	2	234668879	234668883	CATAT	CATATATAT	clustered_events,germline,multiallelic,normal_artifact,chemotherapy_site	UGT1A1	NM_000463.3	0	c.-55_-54insATAT		upstream_gene_variant	Conflicting_classifications_of_pathogenicity|drug_response	Pathogenic(3)|Uncertain_significance(1)|Benign(1)	Irinotecan_response|UGT1A9-related_disorder|not_provided		
2	FANCD2(7.2%)	exon6,c.378-5del	0.072	0.071	975|88	159|14	0.06653	1333|95	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,background	FANCD2	NM_001018115.3	6	c.378-5del		splice_region_variant&intron_variant					
2	FANCD2(5.2%)	exon6,c.378-5dup	0.052	0.037	975|72	159|9	0.05528	1333|78	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5dup		splice_region_variant&intron_variant					
	FANCD2(1.3%)	exon31,c.3061A>G,p.T1021A	0.013	0.003575	1886|24	338|0	0.01355	2548|35	3	10122868	10122868	A	G	PASS	FANCD2	NM_001018115.3	31	c.3061A>G	p.Thr1021Ala	missense_variant					
	TGFBR2(63.6%)	exon4,c.458del,p.K153fs	0.636	0.081	413|781	164|14	0.62578	598|1000	3	30691871	30691873	GAA	GA	multiallelic,normal_artifact,distinguished	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(1)|Benign(2)|Likely_benign(1)	not_provided|Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified		
	MLH1(24.3%)	exon18,c.2040C>T,p.C680=	0.243	0.006815	1076|339	193|0	0.23469	1337|410	3	37090445	37090445	C	T	distinguished	MLH1	NM_000249.4	18	c.2040C>T	p.Cys680=	synonymous_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Benign(1)|Likely_benign(6)	Hereditary_cancer-predisposing_syndrome|Lynch_syndrome|not_provided|Hereditary_nonpolyposis_colorectal_neoplasms|Colorectal_cancer,_hereditary_nonpolyposis,_type_2		
	MYD88(14.9%)	exon2,c.426A>G,p.A142=	0.149	0.167	19|4	4|0	0.17391	19|4	3	38181452	38181452	A	G	PASS	MYD88	NM_002468.5	2	c.426A>G	p.Ala142=	synonymous_variant					
	ANO10(12.9%)	exon2,c.132del,p.D45fs	0.129	0.033	2723|439	649|22	0.11845	4629|622	3	43647212	43647213	CT	C	multiallelic,normal_artifact,distinguished	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		
	ANO10(3.1%)	exon2,c.132dup,p.D45fs	0.031	0.02	2723|117	649|18	0.04142	4629|200	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Autosomal_recessive_spinocerebellar_ataxia_10|not_provided|Autosomal_recessive_cerebellar_ataxia|Abnormal_central_motor_function		
	ANO10(1.0%)	exon2,c.132A>G,p.K44=	0.01	0.00619	3390|42	727|3	0.01080	4855|53	3	43647213	43647213	T	C	background	ANO10	NM_018075.5	2	c.132A>G	p.Lys44=	synonymous_variant					
	PBRM1(6.3%)	exon24,c.3658A>G,p.R1220G	0.063	0.009145	857|57	138|0	0.06061	1085|70	3	52598208	52598208	T	C	PASS	PBRM1	NM_018313.5	24	c.3658A>G	p.Arg1220Gly	missense_variant					
-	PBRM1(34.4%)	exon17,c.1953dup,p.S652fs	0.344	0.043	61|31	23|0	0.31532	76|35	3	52643942	52643942	A	AT	PASS	PBRM1	NM_018313.5	17	c.1953dup	p.Ser652fs	frameshift_variant					
	FOXL2(35.5%)	exon1,c.60C>T,p.T20=	0.355	0.083	28|15	10|0	0.34000	33|17	3	138665505	138665505	G	A	PASS	FOXL2	NM_023067.4	1	c.60C>T	p.Thr20=	synonymous_variant					
	ATR(1.4%)	exon45,c.7571G>A,p.G2524D	0.014	0.018	353|5	62|0	0.01193	414|5	3	142176530	142176530	C	T	PASS	ATR	NM_001184.4	45	c.7571G>A	p.Gly2524Asp	missense_variant					
	ATR(7.5%)	exon10,c.2320del,p.I774fs	0.075	0.054	6685|628	1457|95	0.06723	14373|1036	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrium_neoplasm|not_provided		
	ATR(2.9%)	exon10,c.2320dup,p.I774fs	0.029	0.033	6685|269	1457|74	0.04460	14373|671	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,background	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|Seckel_syndrome_1		
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.0008482	0.0009077	5404|4	1436|0	0.00070	9943|7	3	178936082	178936082	G	A	orientation,strand_bias,weak_evidence,background	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		Papillary_renal_cell_carcinoma,_sporadic|Neoplasm_of_uterine_cervix|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Glioblastoma|Carcinoma_of_esophagus|CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Rare_venous_malformation|PIK3CA-related_overgrowth|Gastric_adenocarcinoma|HEMIFACIAL_MYOHYPERPLASIA,_SOMATIC|Neoplasm_of_the_large_intestine|Abnormal_cardiovascular_system_morphology|Lip_and_oral_cavity_carcinoma|PIK3CA_related_overgrowth_syndrome|Cowden_syndrome|not_provided|Non-small_cell_lung_carcinoma|CLOVES_syndrome|Lung_adenocarcinoma|Breast_neoplasm|Neoplasm_of_brain|Transitional_cell_carcinoma_of_the_bladder|PIK3CA-related_disorder|Neoplasm_of_ovary|Squamous_cell_carcinoma_of_the_head_and_neck|Hepatocellular_carcinoma|CLAPO_syndrome		
1	PIK3CA(0.1%)	exon10,c.1637A>G,p.Q546R	0.001075	0.0009267	5305|7	1379|0	0.00092	9786|9	3	178936095	178936095	A	G	orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1637A>G	p.Gln546Arg	missense_variant	Pathogenic		Neoplasm_of_the_large_intestine|Neoplasm_of_uterine_cervix|Uterine_carcinosarcoma|Glioblastoma|not_provided|Squamous_cell_carcinoma_of_the_head_and_neck|Medulloblastoma|Breast_neoplasm|Gastric_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Prostate_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Malignant_melanoma_of_skin|Neoplasm_of_ovary|Abnormal_cardiovascular_system_morphology|PIK3CA_related_overgrowth_syndrome|Neoplasm_of_brain		
1	PIK3CA(28.8%)	exon21,c.3140A>G,p.H1047R	0.288	0.0008338	6730|2624	2944|2	0.27832	17147|6613	3	178952085	178952085	A	G	PASS	PIK3CA	NM_006218.4	21	c.3140A>G	p.His1047Arg	missense_variant	Pathogenic		Rosette-forming_glioneuronal_tumor|Uterine_carcinosarcoma|Neoplasm_of_uterine_cervix|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Neoplasm_of_the_large_intestine|Glioblastoma|PIK3CA_related_overgrowth_syndrome|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|Carcinoma_of_esophagus|Pancreatic_adenocarcinoma|Neoplasm_of_ovary|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Hepatocellular_carcinoma|Papillary_renal_cell_carcinoma_type_1|Squamous_cell_lung_carcinoma|Carcinoma_of_colon|CLAPO_syndrome|MACRODACTYLY,_SOMATIC|Medulloblastoma|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Rare_venous_malformation|Rare_combined_vascular_malformation|Adrenal_cortex_carcinoma|Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Segmental_undergrowth_associated_with_lymphatic_malformation|Breast_carcinoma|Abnormal_cardiovascular_system_morphology|Neoplasm|Lip_and_oral_cavity_carcinoma|Breast_adenocarcinoma|Non-small_cell_lung_carcinoma|Seborrheic_keratosis|CLOVES_syndrome|not_provided|Lung_adenocarcinoma|Gastric_cancer|Breast_neoplasm|Neoplasm_of_brain|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Klippel-Trenaunay-like-Syndrome|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder|Squamous_cell_carcinoma_of_the_head_and_neck|Malignant_melanoma_of_skin|Congenital_macrodactylia		
	KLHL6(3.0%)	exon2,c.334A>G,p.R112G	0.03	0.029	262|7	42|0	0.02280	300|7	3	183245758	183245758	T	C	orientation	KLHL6	NM_130446.4	2	c.334A>G	p.Arg112Gly	missense_variant					
	BCL6(30.1%)	exon6,c.1427C>T,p.T476M	0.301	0.111	68|24	8|0	0.28283	71|28	3	187446261	187446261	G	A	PASS	BCL6	NM_001706.5	6	c.1427C>T	p.Thr476Met	missense_variant				COSV51652981	
	CLDN16(0.6%)	exon1,c.59del,p.L20*	0.006244	0.001942	4695|38	1022|6	0.00701	7935|56	3	190106172	190106173	GT	G	low_allele_frac	CLDN16	NM_006580.4	1	c.59del	p.Leu20*	frameshift_variant&stop_gained					
	RGS12(31.7%)	exon16,c.3534del,p.K1178fs	0.317	0.027	1173|565	256|6	0.29894	1712|730	4	3430398	3430399	GA	G	distinguished	RGS12	NM_198229.2	16	c.3534del	p.Lys1178fs	frameshift_variant					
	SLIT2(3.7%)	exon12,c.1130+2T>C	0.037	0.006798	1427|53	190|0	0.03193	1819|60	4	20521078	20521078	T	C	PASS	SLIT2	NM_004787.4	12	c.1130+2T>C		splice_donor_variant&intron_variant					
	SLIT2(27.0%)	exon19,c.1931C>T,p.T644I	0.27	0.015	304|113	82|0	0.27195	340|127	4	20541162	20541162	C	T	PASS	SLIT2	NM_004787.4	19	c.1931C>T	p.Thr644Ile	missense_variant					
	PDGFRA(23.9%)	exon3,c.83C>A,p.P28H	0.239	0.002445	2745|848	748|2	0.22461	4077|1181	4	55127295	55127295	C	A	distinguished	PDGFRA	NM_006206.6	3	c.83C>A	p.Pro28His	missense_variant				COSV99956597	
	PDGFRA(7.6%)	exon3,c.248C>T,p.T83M	0.076	0.007201	1447|121	297|1	0.07807	1854|157	4	55127460	55127460	C	T	PASS	PDGFRA	NM_006206.6	3	c.248C>T	p.Thr83Met	missense_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(5)	not_provided|Hereditary_cancer-predisposing_syndrome|PDGFRA-related_disorder|Gastrointestinal_stromal_tumor|Polyps,_multiple_and_recurrent_inflammatory_fibroid,_gastrointestinal|Ovarian_cancer		
	KDR(26.0%)	exon14,c.1990C>T,p.R664C	0.26	0.005573	973|335	224|0	0.25994	1247|438	4	55968673	55968673	G	A	PASS	KDR	NM_002253.3	14	c.1990C>T	p.Arg664Cys	missense_variant&splice_region_variant				COSV55776299	
	SEC31A(57.5%)	exon11,c.1384del,p.I462fs	0.575	0.027	1346|1953	593|16	0.57957	2235|3081	4	83785564	83785566	ATT	AT	multiallelic,distinguished	SEC31A	NM_001077207.4	11	c.1384del	p.Ile462fs	frameshift_variant					
	TET2(24.9%)	exon3,c.3368C>A,p.P1123H	0.249	0.00671	778|243	176|0	0.23832	978|306	4	106158467	106158467	C	A	PASS	TET2	NM_001127208.3	3	c.3368C>A	p.Pro1123His	missense_variant				COSV54397834	
	TET2(1.2%)	exon4,c.3426A>G,p.K1142=	0.012	0.006573	762|13	172|0	0.01274	930|12	4	106162512	106162512	A	G	background	TET2	NM_001127208.3	4	c.3426A>G	p.Lys1142=	synonymous_variant					
	INPP4B(1.7%)	exon24,c.2409A>G,p.K803=	0.017	0.00808	857|13	155|0	0.01160	1108|13	4	143007375	143007375	T	C	suspected_bg	INPP4B	NM_001101669.3	24	c.2409A>G	p.Lys803=	synonymous_variant					
	INPP4B(9.7%)	exon16,c.1246A>G,p.N416D	0.097	0.014	545|63	100|0	0.10475	641|75	4	143094898	143094898	T	C	PASS	INPP4B	NM_001101669.3	16	c.1246A>G	p.Asn416Asp	missense_variant					
-	FBXW7(11.0%)	exon4,c.585-6_585-5del	0.11	0.091	17|4	6|0	0.08696	42|4	4	153268227	153268229	CAA	C	germline,multiallelic,normal_artifact	FBXW7	NM_033632.3	4	c.585-6_585-5del		splice_region_variant&intron_variant					
-	FBXW7(42.4%)	exon4,c.585-5del	0.424	0.213	17|18	6|2	0.36364	42|24	4	153268227	153268229	CAA	CA	germline,multiallelic,normal_artifact,distinguished	FBXW7	NM_033632.3	4	c.585-5del		splice_region_variant&intron_variant					
	FAT1(3.6%)	exon14,c.9697C>T,p.R3233C	0.036	0.002065	3402|130	644|0	0.03723	5094|197	4	187532696	187532696	G	A	PASS	FAT1	NM_005245.4	14	c.9697C>T	p.Arg3233Cys	missense_variant	Uncertain_significance		not_provided		
	FAT1(1.6%)	exon4,c.3620A>G,p.Q1207R	0.016	0.016	413|8	81|0	0.01590	495|8	4	187560898	187560898	T	C	PASS	FAT1	NM_005245.4	4	c.3620A>G	p.Gln1207Arg	missense_variant					
	SDHA(8.6%)	exon5,c.614A>G,p.Y205C	0.086	0.001871	2693|253	580|0	0.08095	3849|339	5	226155	226155	A	G	PASS	SDHA	NM_004168.4	5	c.614A>G	p.Tyr205Cys	missense_variant	Uncertain_significance		Mitochondrial_complex_II_deficiency,_nuclear_type_1|Paragangliomas_5		
	SDHA(1.3%)	exon7,c.853C>A,p.L285I	0.013	0.019	407|5	72|0	0.01046	473|5	5	231073	231073	C	A	PASS	SDHA	NM_004168.4	7	c.853C>A	p.Leu285Ile	missense_variant					
	TERT(1.6%)	exon3,c.1709A>G,p.K570R	0.016	0.023	344|5	56|0	0.01241	398|5	5	1282604	1282604	T	C	PASS	TERT	NM_198253.3	3	c.1709A>G	p.Lys570Arg	missense_variant					
	MSH3(4.4%)	exon7,c.1148del,p.K383fs	0.044	0.02	5133|270	1118|22	0.04395	9224|424	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,distinguished	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic/Likely_pathogenic		MSH3-related_disorder|Endometrial_carcinoma|Familial_adenomatous_polyposis_4|not_provided|Hereditary_cancer-predisposing_syndrome		
	MSH3(1.9%)	exon7,c.1148dup,p.N385fs	0.019	0.019	5133|121	1118|26	0.02226	9224|210	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|Endometrial_carcinoma|Familial_adenomatous_polyposis_4|Hereditary_cancer-predisposing_syndrome		
-	APC(3.9%)	exon5,c.423-5_423-4del	0.039	0.019	358|26	85|1	0.05375	581|33	5	112111309	112111311	TAA	T	multiallelic,normal_artifact	APC	NM_000038.6	5	c.423-5_423-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1		
-	APC(29.3%)	exon5,c.423-4del	0.293	0.164	358|194	85|21	0.30336	581|253	5	112111309	112111311	TAA	TA	multiallelic,normal_artifact,distinguished	APC	NM_000038.6	5	c.423-4del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Desmoid_disease,_hereditary|Familial_adenomatous_polyposis_1|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Hepatocellular_carcinoma|Colorectal_cancer|Gastric_cancer|APC-related_disorder|not_specified|not_provided		
-	APC(8.8%)	exon5,c.423-4dup	0.088	0.164	358|66	85|19	0.13670	581|92	5	112111309	112111311	TAA	TAAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	5	c.423-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Familial_adenomatous_polyposis_1|Hereditary_cancer-predisposing_syndrome|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Colorectal_cancer|Desmoid_disease,_hereditary|Hepatocellular_carcinoma|Gastric_cancer		
	APC(0.6%)	exon16,c.6155A>G,p.K2052R	0.006184	0.002792	1961|11	430|1	0.00670	2521|17	5	112177446	112177446	A	G	background,low_allele_frac	APC	NM_000038.6	16	c.6155A>G	p.Lys2052Arg	missense_variant	Uncertain_significance		Familial_adenomatous_polyposis_1|Hereditary_cancer-predisposing_syndrome		
-	APC(0.7%)	exon16,c.6579del,p.V2194fs	0.007364	0.007005	1668|13	296|1	0.00733	2167|16	5	112177863	112177864	GA	G	suspected_bg,low_allele_frac	APC	NM_000038.6	16	c.6579del	p.Val2194fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1		
	RAD50(8.6%)	exon13,c.2165del,p.K722fs	0.086	0.049	9679|1006	2851|186	0.08368	30356|2772	5	131931451	131931453	TAA	TA	clustered_events,multiallelic,normal_artifact,background	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome		
	RAD50(0.2%)	exon13,c.2164_2165del,p.K722fs	0.001916	0.001987	9679|31	2851|7	0.00263	30356|80	5	131931451	131931453	TAA	T	clustered_events,multiallelic,normal_artifact,low_allele_frac	RAD50	NM_005732.4	13	c.2164_2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Nijmegen_breakage_syndrome-like_disorder		
	RAD50(1.6%)	exon13,c.2165dup,p.E723fs	0.016	0.026	9679|245	2851|105	0.03229	30356|1013	5	131931451	131931453	TAA	TAAA	clustered_events,multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		
	CSF1R(2.7%)	exon11,c.1596_1598del,p.L533del	0.027	0.12	248|5	7|0	0.01661	296|5	5	149447805	149447808	GAGC	G	slippage,suspected_bg	CSF1R	NM_005211.4	11	c.1596_1598del	p.Leu533del	disruptive_inframe_deletion					
	CSF1R(38.4%)	exon5,c.726C>T,p.T242=	0.384	0.333	36|21	4|1	0.37097	39|23	5	149457678	149457678	G	A	germline,normal_artifact,Germline	CSF1R	NM_005211.4	5	c.726C>T	p.Thr242=	synonymous_variant	Benign		Hereditary_diffuse_leukoencephalopathy_with_spheroids|Brain_abnormalities,_neurodegeneration,_and_dysosteosclerosis|not_provided		
	GABRA6(2.3%)	exon2,c.47del,p.N16fs	0.023	0.018	302|5	66|0	0.01366	361|5	5	161113240	161113241	GA	G	PASS	GABRA6	NM_000811.3	2	c.47del	p.Asn16fs	frameshift_variant					
	GABRA6(0.8%)	exon4,c.353del,p.F118fs	0.008478	0.009609	1048|10	215|1	0.00900	1321|12	5	161116077	161116078	CT	C	suspected_bg	GABRA6	NM_000811.3	4	c.353del	p.Phe118fs	frameshift_variant					
	NPM1(7.8%)	exon6,c.476C>T,p.A159V	0.078	0.057	298|23	39|1	0.06366	353|24	5	170819934	170819934	C	T	normal_artifact	NPM1	NM_002520.7	6	c.476C>T	p.Ala159Val	missense_variant					
	FGFR4(44.1%)	exon2,c.28G>A,p.V10I	0.441	0.426	43|42	4|3	0.51064	46|48	5	176516631	176516631	G	A	germline,normal_artifact,Germline	FGFR4	NM_213647.3	2	c.28G>A	p.Val10Ile	missense_variant	Benign		not_provided|FGFR4-related_disorder		
	FGFR4(94.1%)	exon6,c.702C>T,p.R234=	0.941	0.75	0|22	0|3	1.00000	0|24	5	176518784	176518784	C	T	germline,normal_artifact,Germline	FGFR4	NM_213647.3	6	c.702C>T	p.Arg234=	synonymous_variant	Benign		FGFR4-related_disorder		
	FGFR4(2.4%)	exon9,c.1209_1212del,p.A404fs	0.024	0.045	198|4	22|0	0.02260	173|4	5	176520279	176520283	CCCCG	C	slippage,suspected_bg	FGFR4	NM_213647.3	9	c.1209_1212del	p.Ala404fs	frameshift_variant					
	FGFR4(2.9%)	exon9,c.1202G>C,p.R401P	0.029	0.042	183|9	21|0	0.05419	192|11	5	176520283	176520283	G	C	strand_bias,background	FGFR4	NM_213647.3	9	c.1202G>C	p.Arg401Pro	missense_variant					
	NSD1(62.2%)	exon23,c.6829T>C,p.L2277=	0.622	0.251	17|28	10|2	0.62500	18|30	5	176721198	176721198	T	C	germline,normal_artifact,Germline	NSD1	NM_022455.5	23	c.6829T>C	p.Leu2277=	synonymous_variant	Benign		not_specified|Sotos_syndrome|Inborn_genetic_diseases		
	FLT4(87.5%)	exon19,c.2670C>G,p.H890Q	0.875	0.667	0|9	0|1	1.00000	0|11	5	180046344	180046344	G	C	germline,normal_artifact	FLT4	NM_182925.5	19	c.2670C>G	p.His890Gln	missense_variant	Benign		not_provided|Hereditary_lymphedema_type_I|not_specified|Congenital_heart_defects,_multiple_types,_7		
	FLT4(48.6%)	exon5,c.552G>T,p.V184=	0.486	0.136	23|21	6|0	0.46667	24|21	5	180057067	180057067	C	A	germline	FLT4	NM_182925.5	5	c.552G>T	p.Val184=	synonymous_variant					
	FLT4(2.0%)	exon2,c.104C>T,p.T35M	0.02	0.019	267|4	62|0	0.01208	327|4	5	180058733	180058733	G	A	PASS	FLT4	NM_182925.5	2	c.104C>T	p.Thr35Met	missense_variant					
	CYP21A2(64.7%)	exon1,c.29_31del,p.L10del	0.647	0.667	12|20	0|1	0.56098	18|23	6	32006214	32006217	CCTG	C	germline,normal_artifact,Germline	CYP21A2	NM_000500.9	1	c.29_31del	p.Leu10del	disruptive_inframe_deletion	Benign		not_specified|not_provided		
	CYP21A2(96.1%)	exon1,c.118C>T,p.L40=	0.961	0.667	0|29	0|1	1.00000	0|31	6	32006317	32006317	C	T	germline,normal_artifact,Germline	CYP21A2	NM_000500.9	1	c.118C>T	p.Leu40=	synonymous_variant	Benign		Classic_congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency|not_provided|not_specified		
	CYP21A2(95.5%)	exon1,c.138C>A,p.P46=	0.955	0.667	0|27	0|1	1.00000	0|27	6	32006337	32006337	C	A	germline,normal_artifact,Germline	CYP21A2	NM_000500.9	1	c.138C>A	p.Pro46=	synonymous_variant	Benign		Classic_congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency|not_specified		
	FANCE(54.1%)	exon2,c.387A>C,p.P129=	0.541	0.398	11|15	3|1	0.57143	12|16	6	35423662	35423662	A	C	germline,normal_artifact,Germline	FANCE	NM_021922.3	2	c.387A>C	p.Pro129=	synonymous_variant	Benign		not_provided|Fanconi_anemia_complementation_group_E|not_specified		
	CCND3(56.8%)	exon5,c.775T>G,p.S259A	0.568	0.667	12|14	1|3	0.51852	13|14	6	41903782	41903782	A	C	germline,normal_artifact,Germline	CCND3	NM_001760.5	5	c.775T>G	p.Ser259Ala	missense_variant				COSV57827647	
	CCND3(19.9%)	exon5,c.764T>C,p.L255P	0.199	0.2	19|6	3|0	0.22222	21|6	6	41903793	41903793	A	G	PASS	CCND3	NM_001760.5	5	c.764T>C	p.Leu255Pro	missense_variant					
	CCND3(17.8%)	exon3,c.562C>A,p.L188I	0.178	0.073	102|24	16|0	0.19424	112|27	6	41904985	41904985	G	T	PASS	CCND3	NM_001760.5	3	c.562C>A	p.Leu188Ile	missense_variant					
	TTK(30.5%)	exon22,c.2560del,p.R854fs	0.305	0.021	1835|984	688|22	0.32283	3203|1527	6	80751896	80751898	GAA	GA	clustered_events,multiallelic,distinguished	TTK	NM_003318.5	22	c.2560del	p.Arg854fs	frameshift_variant					
	TTK(8.3%)	exon22,c.2560dup,p.R854fs	0.083	0.022	1835|271	688|21	0.13456	3203|498	6	80751896	80751898	GAA	GAAA	clustered_events,multiallelic,distinguished	TTK	NM_003318.5	22	c.2560dup	p.Arg854fs	frameshift_variant					
	CEP162(0.6%)	exon12,c.1354del,p.I452*	0.005574	0.004035	4029|28	998|3	0.00464	7508|35	6	84896096	84896097	AT	A	suspected_bg,low_allele_frac	CEP162	NM_014895.4	12	c.1354del	p.Ile452*	frameshift_variant&stop_gained					
	ROS1(0.1%)	exon36,c.5825G>A,p.R1942Q	0.001478	0.001131	12556|19	3813|5	0.00135	34018|46	6	117641146	117641146	C	T	low_allele_frac	ROS1	NM_002944.3	36	c.5825G>A	p.Arg1942Gln	missense_variant					
	ROS1(15.9%)	exon23,c.3594T>C,p.Y1198=	0.159	0.003328	1640|320	354|0	0.14871	2181|381	6	117681026	117681026	A	G	PASS	ROS1	NM_002944.3	23	c.3594T>C	p.Tyr1198=	synonymous_variant					
	ROS1(0.8%)	exon15,c.2200A>G,p.T734A	0.008006	0.033	703|6	73|2	0.00708	842|6	6	117706950	117706950	T	C	normal_artifact	ROS1	NM_002944.3	15	c.2200A>G	p.Thr734Ala	missense_variant					
	ZBTB2(33.5%)	exon3,c.1213G>A,p.A405T	0.335	0.097	34|17	10|0	0.32075	36|17	6	151686988	151686988	C	T	clustered_events	ZBTB2	NM_020861.3	3	c.1213G>A	p.Ala405Thr	missense_variant					
	ESR1(1.3%)	exon4,c.899G>A,p.R300H	0.013	0.003587	2847|41	660|2	0.01500	4401|67	6	152265446	152265446	G	A	PASS	ESR1	NM_000125.4	4	c.899G>A	p.Arg300His	missense_variant				COSV99240618	
	PMS2(1.9%)	exon11,c.1239del,p.D414fs	0.019	0.017	563|12	103|1	0.01806	761|14	7	6027156	6027157	CT	C	multiallelic,slippage,suspected_bg	PMS2	NM_000535.7	11	c.1239del	p.Asp414fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_4		
	PMS2(1.8%)	exon11,c.1239dup,p.D414fs	0.018	0.00988	563|13	103|1	0.01806	761|14	7	6027156	6027157	CT	CTT	multiallelic,slippage	PMS2	NM_000535.7	11	c.1239dup	p.Asp414fs	frameshift_variant	Pathogenic		Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colon_cancer|not_provided|Lynch_syndrome_4		
2	PMS2(7.3%)	exon7,c.706-8_706-4del	0.073	0.008224	176|141	92|2	0.12788	1364|200	7	6037057	6037062	GAAAAA	G	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-8_706-4del		splice_region_variant&intron_variant					
2	PMS2(13.0%)	exon7,c.706-7_706-4del	0.13	0.017	176|246	92|4	0.23241	1364|413	7	6037057	6037062	GAAAAA	GA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-7_706-4del		splice_region_variant&intron_variant	Benign		not_specified		
2	PMS2(19.9%)	exon7,c.706-6_706-4del	0.199	0.045	176|344	92|12	0.32874	1364|668	7	6037057	6037062	GAAAAA	GAA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-6_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|not_provided		
2	PMS2(31.6%)	exon7,c.706-5_706-4del	0.316	0.128	176|509	92|41	0.43048	1364|1031	7	6037057	6037062	GAAAAA	GAAA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-5_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_4|not_specified|Hereditary_cancer-predisposing_syndrome|PMS2-related_disorder|not_provided|Lynch_syndrome		
	EGFR(28.6%)	exon2,c.125G>A,p.G42D	0.286	0.002537	3372|1355	955|1	0.27421	5643|2132	7	55210015	55210015	G	A	PASS	EGFR	NM_005228.5	2	c.125G>A	p.Gly42Asp	missense_variant				COSV51838271	
1	EGFR(0.1%)	exon20,c.2389T>A,p.C797S	0.0009732	0.004109	1972|4	327|1	0.00186	2686|5	7	55249091	55249091	T	A	base_qual,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>A	p.Cys797Ser	missense_variant	Uncertain_significance		EGFR-related_lung_cancer|Non-small_cell_lung_carcinoma		
1	EGFR(0.3%)	exon20,c.2392C>A,p.L798I	0.002682	0.004065	1907|5	325|0	0.00270	2585|7	7	55249094	55249094	C	A	orientation,weak_evidence	EGFR	NM_005228.5	20	c.2392C>A	p.Leu798Ile	missense_variant					
	MAGI2(45.3%)	exon22,c.4329C>G,p.P1443=	0.453	0.5	5|4	0|0	0.50000	5|5	7	77648671	77648671	G	C	germline,Germline	MAGI2	NM_012301.4	22	c.4329C>G	p.Pro1443=	synonymous_variant	Benign		not_specified|not_provided|Nephrotic_syndrome_15		
	MAGI2(54.8%)	exon19,c.3357A>G,p.L1119=	0.548	0.5	18|22	2|2	0.53846	24|28	7	77756580	77756580	T	C	germline,normal_artifact,Germline	MAGI2	NM_012301.4	19	c.3357A>G	p.Leu1119=	synonymous_variant	Benign		not_provided|Nephrotic_syndrome_15|not_specified		
	MAGI2(50.1%)	exon19,c.3213G>A,p.S1071=	0.501	0.5	13|14	1|1	0.48387	16|15	7	77756724	77756724	C	T	germline,normal_artifact,Germline	MAGI2	NM_012301.4	19	c.3213G>A	p.Ser1071=	synonymous_variant	Benign		Nephrotic_syndrome_15|not_provided|not_specified		
	CYP3A5(8.9%)	exon11,c.1028C>T,p.A343V	0.089	0.001557	3054|303	739|0	0.09020	4680|464	7	99250401	99250401	G	A	PASS	CYP3A5	NM_000777.5	11	c.1028C>T	p.Ala343Val	missense_variant&splice_region_variant					
1	MET(0.1%)	exon14,c.2888-1G>A	0.001016	0.0004697	14414|17	4228|1	0.00079	41656|33	7	116411902	116411902	G	A	strand_bias	MET	NM_000245.4	14	c.2888-1G>A		splice_acceptor_variant&intron_variant					
1	MET(0.1%)	exon14,c.3028G>A,p.D1010N	0.0008697	0.0007158	13966|11	4157|2	0.00098	44878|44	7	116412043	116412043	G	A	strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>A	p.Asp1010Asn	missense_variant&splice_region_variant	Uncertain_significance		Lung_carcinoma|Hereditary_cancer-predisposing_syndrome		
1	MET(0.1%)	exon14,c.3028+1G>A	0.001021	0.000674	13948|16	4166|2	0.00116	44861|52	7	116412044	116412044	G	A	PASS	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided		
	MET(10.6%)	exon21,c.4052A>G,p.H1351R	0.106	0.001271	4587|536	985|0	0.09682	7416|795	7	116436057	116436057	A	G	PASS	MET	NM_000245.4	21	c.4052A>G	p.His1351Arg	missense_variant	Uncertain_significance		not_specified|Hereditary_cancer-predisposing_syndrome|Renal_cell_carcinoma		
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0009393	0.001989	9084|9	2452|4	0.00064	21701|14	7	140453137	140453137	C	T	normal_artifact,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|not_provided|Non-small_cell_lung_carcinoma		
	BRAF(8.8%)	exon10,c.1208del,p.P403fs	0.088	0.003077	2075|209	416|2	0.08462	2845|263	7	140482926	140482927	AG	A	distinguished	BRAF	NM_004333.6	10	c.1208del	p.Pro403fs	frameshift_variant	Uncertain_significance		RASopathy		
	KEL(0.5%)	exon9,c.932C>T,p.A311V	0.005322	0.007708	2442|15	345|1	0.00513	3491|18	7	142651036	142651036	G	A	low_allele_frac	KEL	NM_000420.3	9	c.932C>T	p.Ala311Val	missense_variant					
	KMT2C(1.8%)	exon49,c.12353C>T,p.A4118V	0.018	0.003423	2292|44	376|0	0.01716	3093|54	7	151849963	151849963	G	A	PASS	KMT2C	NM_170606.3	49	c.12353C>T	p.Ala4118Val	missense_variant				COSV51525165	
	KMT2C(0.3%)	exon49,c.12322C>A,p.R4108=	0.003368	0.00311	2783|10	442|0	0.00344	3766|13	7	151849994	151849994	G	T	low_allele_frac	KMT2C	NM_170606.3	49	c.12322C>A	p.Arg4108=	synonymous_variant					
-	KMT2C(59.6%)	exon38,c.8390del,p.K2797fs	0.596	0.049	3744|5909	2072|131	0.57602	9908|13461	7	151874147	151874149	CTT	CT	clustered_events,multiallelic,suspected_bg	KMT2C	NM_170606.3	38	c.8390del	p.Lys2797fs	frameshift_variant					
-	KMT2C(1.2%)	exon38,c.8390dup,p.E2798fs	0.012	0.032	3744|143	2072|91	0.04011	9908|414	7	151874147	151874149	CTT	CTTT	clustered_events,multiallelic,background	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		
	KMT2C(1.8%)	exon14,c.2493T>C,p.T831=	0.018	0.009902	776|13	108|0	0.01810	868|16	7	151945026	151945026	A	G	PASS	KMT2C	NM_170606.3	14	c.2493T>C	p.Thr831=	synonymous_variant					
	KMT2C(2.0%)	exon14,c.2185_2189delinsGATTA,p.N729_S730>DY	0.02	0.04	446|7	79|2	0.02449	478|12	7	151945330	151945334	GAATT	TAATC	haplotype,normal_artifact	KMT2C	NM_170606.3	14	c.2185_2189delinsGATTA	p.Asn729_Ser730delinsAspTyr	missense_variant					
	KMT2C(5.7%)	exon9,c.1275A>G,p.V425=	0.057	0.014	478|28	99|0	0.05699	546|33	7	151960125	151960125	T	C	PASS	KMT2C	NM_170606.3	9	c.1275A>G	p.Val425=	synonymous_variant					
	KMT2C(1.8%)	exon8,c.1077T>C,p.C359=	0.018	0.015	565|10	101|0	0.01509	718|11	7	151962230	151962230	A	G	PASS	KMT2C	NM_170606.3	8	c.1077T>C	p.Cys359=	synonymous_variant				COSV100072521	
	RP1L1(2.3%)	exon4,c.3971_3972delinsGG,p.E1324G	0.023	0.01	3292|134	553|13	0.00380	11277|43	8	10467636	10467637	TT	CC	clustered_events,haplotype,orientation	RP1L1	NM_178857.6	4	c.3971_3972delinsGG	p.Glu1324Gly	missense_variant					
	PRKDC(6.6%)	exon35,c.4360T>C,p.C1454R	0.066	0.059	167|12	20|0	0.05769	196|12	8	48801129	48801129	A	G	PASS	PRKDC	NM_006904.7	35	c.4360T>C	p.Cys1454Arg	missense_variant					
	PRKDC(1.8%)	exon21,c.2419G>A,p.D807N	0.018	0.018	421|7	64|0	0.01411	489|7	8	48839754	48839754	C	T	PASS	PRKDC	NM_006904.7	21	c.2419G>A	p.Asp807Asn	missense_variant&splice_region_variant					
	PREX2(0.5%)	exon6,c.584C>T,p.A195V	0.004782	0.004215	1607|9	257|0	0.00509	2148|11	8	68942772	68942772	C	T	low_allele_frac	PREX2	NM_024870.4	6	c.584C>T	p.Ala195Val	missense_variant					
	PREX2(3.8%)	exon15,c.1630T>C,p.F544L	0.038	0.024	476|16	58|0	0.02754	565|16	8	68989692	68989692	T	C	PASS	PREX2	NM_024870.4	15	c.1630T>C	p.Phe544Leu	missense_variant					
	PREX2(0.9%)	exon16,c.1694C>T,p.S565L	0.008602	0.009414	1874|17	283|1	0.00967	2355|23	8	68992729	68992729	C	T	background	PREX2	NM_024870.4	16	c.1694C>T	p.Ser565Leu	missense_variant				COSV55753944	
	PREX2(1.9%)	exon39,c.4759C>A,p.P1587T	0.019	0.034	211|4	38|0	0.01639	240|4	8	69136845	69136845	C	A	PASS	PREX2	NM_024870.4	39	c.4759C>A	p.Pro1587Thr	missense_variant					
	PREX2(79.6%)	exon40,c.4797A>G,p.P1599=	0.796	0.5	0|4	0|0	1.00000	0|3	8	69143589	69143589	A	G	germline	PREX2	NM_024870.4	40	c.4797A>G	p.Pro1599=	synonymous_variant	Benign		PREX2-related_disorder		
	KCNB2(20.4%)	exon2,c.575C>T,p.A192V	0.204	0.018	308|83	57|0	0.20877	379|100	8	73480544	73480544	C	T	PASS	KCNB2	NM_004770.3	2	c.575C>T	p.Ala192Val	missense_variant					
	NBN(0.5%)	exon11,c.1651del,p.R551fs	0.005036	0.004476	15332|115	4116|22	0.00601	49297|298	8	90965665	90965666	CT	C	normal_artifact,low_allele_frac	NBN	NM_002485.5	11	c.1651del	p.Arg551fs	frameshift_variant	Pathogenic/Likely_pathogenic		Aplastic_anemia|Hereditary_cancer-predisposing_syndrome		
	NBN(0.1%)	exon11,c.1651A>G,p.R551G	0.001118	0.001106	15854|21	4246|4	0.00101	49512|50	8	90965666	90965666	T	C	low_allele_frac	NBN	NM_002485.5	11	c.1651A>G	p.Arg551Gly	missense_variant	Uncertain_significance		Microcephaly,_normal_intelligence_and_immunodeficiency		
	UBR5(24.9%)	exon45,c.6360del,p.E2121fs	0.249	0.012	7743|2715	1908|37	0.24665	18473|6048	8	103289348	103289350	CTT	CT	multiallelic,distinguished	UBR5	NM_015902.6	45	c.6360del	p.Glu2121fs	frameshift_variant					
	UBR5(2.4%)	exon45,c.6360dup,p.E2121fs	0.024	0.02	7743|296	1908|47	0.03450	18473|660	8	103289348	103289350	CTT	CTTT	multiallelic,suspected_bg	UBR5	NM_015902.6	45	c.6360dup	p.Glu2121fs	frameshift_variant					
	MYC(17.3%)	exon3,c.1069T>C,p.C357R	0.173	0.063	67|14	18|0	0.18605	70|16	8	128752908	128752908	T	C	PASS	MYC	NM_002467.6	3	c.1069T>C	p.Cys357Arg	missense_variant					
	MLLT3(6.7%)	exon5,c.531_533del,p.S178del	0.067	0.01	735|66	217|2	0.14912	3960|694	9	20414310	20414316	ACTGCTG	ACTG	clustered_events,multiallelic,suspected_bg	MLLT3	NM_004529.4	5	c.531_533del	p.Ser178del	disruptive_inframe_deletion					
	MLLT3(3.2%)	exon5,c.498_500del,p.S167del	0.032	0.062	401|17	99|8	0.01618	2553|42	9	20414343	20414346	ACTG	A	clustered_events,multiallelic,slippage,suspected_bg	MLLT3	NM_004529.4	5	c.498_500del	p.Ser167del	disruptive_inframe_deletion					
	MLLT3(8.6%)	exon5,c.498_500dup,p.S167dup	0.086	0.006121	401|63	99|0	0.04346	2553|116	9	20414343	20414346	ACTG	ACTGCTG	clustered_events,multiallelic,slippage	MLLT3	NM_004529.4	5	c.498_500dup	p.Ser167dup	disruptive_inframe_insertion					
-	PTCH1(30.0%)	exon22,c.3606del,p.S1203fs	0.3	0.014	364|152	85|0	0.28769	463|187	9	98211548	98211549	TG	T	distinguished	PTCH1	NM_000264.5	22	c.3606del	p.Ser1203fs	frameshift_variant					
	ABL1(2.1%)	exon11,c.1826_1828del,p.K609del	0.021	0.021	642|13	104|2	0.01646	956|16	9	133759489	133759492	CAAG	C	slippage,suspected_bg	ABL1	NM_005157.6	11	c.1826_1828del	p.Lys609del	disruptive_inframe_deletion					
	ABL1(1.8%)	exon11,c.2799A>G,p.K933=	0.018	0.011	454|7	100|0	0.01211	571|7	9	133760476	133760476	A	G	PASS	ABL1	NM_005157.6	11	c.2799A>G	p.Lys933=	synonymous_variant					
	ABL1(0.8%)	exon11,c.2870A>G,p.K957R	0.008425	0.006643	859|9	174|0	0.00751	1190|9	9	133760547	133760547	A	G	PASS	ABL1	NM_005157.6	11	c.2870A>G	p.Lys957Arg	missense_variant					
	TSC1(3.9%)	exon23,c.3127_3129del,p.S1043del	0.039	0.031	184|7	31|0	0.03509	220|8	9	135771987	135771990	CGCT	C	slippage,suspected_bg	TSC1	NM_000368.5	23	c.3127_3129del	p.Ser1043del	conservative_inframe_deletion	Benign/Likely_benign		TSC1-related_condition|Hereditary_cancer-predisposing_syndrome|Tuberous_sclerosis_1|Tuberous_sclerosis_syndrome		
-	TSC1(10.9%)	exon21,c.2626-8_2626-4del	0.109	0.033	14|25	4|0	0.08681	263|25	9	135773000	135773005	GAAAAA	G	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-8_2626-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|TSC1-related_condition		
-	TSC1(12.3%)	exon21,c.2626-5_2626-4del	0.123	0.08	14|19	4|1	0.09932	263|29	9	135773000	135773005	GAAAAA	GAAA	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4del		splice_region_variant&intron_variant	Benign		not_provided|not_specified|Tuberous_sclerosis_1|Lymphangiomyomatosis|Hereditary_cancer-predisposing_syndrome|Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_syndrome		
-	TSC1(8.0%)	exon21,c.2626-4dup	0.08	0.392	14|10	4|3	0.05735	263|16	9	135773000	135773005	GAAAAA	GAAAAAA	multiallelic,normal_artifact,distinguished	TSC1	NM_000368.5	21	c.2626-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|Tuberous_sclerosis_1|Lymphangiomyomatosis|Isolated_focal_cortical_dysplasia_type_II|not_specified|Hereditary_cancer-predisposing_syndrome		
-	TSC1(14.2%)	exon21,c.2626-5_2626-4dup	0.142	0.126	14|13	4|2	0.14052	263|43	9	135773000	135773005	GAAAAA	GAAAAAAA	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4dup		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Tuberous_sclerosis_1|Isolated_focal_cortical_dysplasia_type_II|Lymphangiomyomatosis		
	NOTCH1(3.8%)	exon34,c.7244_7246del,p.P2415del	0.038	0.028	234|8	35|0	0.02676	291|8	9	139390944	139390947	TGTG	T	slippage,suspected_bg	NOTCH1	NM_017617.5	34	c.7244_7246del	p.Pro2415del	disruptive_inframe_deletion	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Likely_benign(5)	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Adams-Oliver_syndrome_5|Aortic_valve_disease_1|Connective_tissue_disorder		
	NOTCH1(97.6%)	exon3,c.312T>C,p.N104=	0.976	0.81	0|53	0|3	1.00000	0|53	9	139418260	139418260	A	G	germline,normal_artifact,Germline	NOTCH1	NM_017617.5	3	c.312T>C	p.Asn104=	synonymous_variant	Benign		Aortic_valve_disease_1|Adams-Oliver_syndrome_5|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified		
	SKIDA1(4.2%)	exon4,c.1269_1271del,p.E424del	0.042	0.052	141|6	19|0	0.04192	160|7	10	21805480	21805483	TTCC	T	haplotype,slippage,suspected_bg	SKIDA1	NM_207371.4	4	c.1269_1271del	p.Glu424del	disruptive_inframe_deletion					
	SVIL(27.6%)	exon29,c.4281del,p.C1428fs	0.276	0.00536	1709|667	413|3	0.27896	2608|1009	10	29760142	29760143	AG	A	PASS	SVIL	NM_003174.3	29	c.4281del	p.Cys1428fs	frameshift_variant					
	RET(0.2%)	exon16,c.2768T>C,p.L923P	0.002095	0.002015	9161|25	1833|2	0.00252	19763|50	10	43617431	43617431	T	C	low_allele_frac	RET	NM_020975.6	16	c.2768T>C	p.Leu923Pro	missense_variant					
	TFAM(35.9%)	exon4,c.441del,p.E148fs	0.359	0.064	1311|824	439|31	0.35520	2153|1186	10	60148569	60148571	CAA	CA	multiallelic,normal_artifact,background	TFAM	NM_003201.3	4	c.441del	p.Glu148fs	frameshift_variant&splice_region_variant	Likely_pathogenic		Mitochondrial_DNA_depletion_syndrome_15_(hepatocerebral_type)		
-	PTEN(17.0%)	exon8,c.802-4_802-3del	0.17	0.009766	155|107	51|1	0.24337	628|202	10	89720633	89720636	CTTT	CT	germline,multiallelic,normal_artifact,suspected_bg	PTEN	NM_000314.8	8	c.802-4_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	PTEN(40.3%)	exon8,c.802-3del	0.403	0.16	155|232	51|21	0.43372	628|481	10	89720633	89720636	CTTT	CTT	germline,multiallelic,normal_artifact,Germline	PTEN	NM_000314.8	8	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|PTEN_hamartoma_tumor_syndrome|Breast_and/or_ovarian_cancer|not_specified|Hereditary_cancer-predisposing_syndrome		
	FGFR2(2.5%)	exon4,c.429del,p.F143fs	0.025	0.017	503|15	76|0	0.03471	584|21	10	123324040	123324041	CA	C	PASS	FGFR2	NM_000141.5	4	c.429del	p.Phe143fs	frameshift_variant					
	FGFR2(1.3%)	exon4,c.390C>T,p.S130=	0.013	0.016	513|8	85|0	0.01325	596|8	10	123324080	123324080	G	A	PASS	FGFR2	NM_000141.5	4	c.390C>T	p.Ser130=	synonymous_variant	Likely_benign		FGFR2-related_craniosynostosis		
	RRM1(1.3%)	exon19,c.2308_2310del,p.K770del	0.013	0.00128	5433|68	923|0	0.01034	10623|111	11	4159539	4159542	GAGA	G	chemotherapy_site	RRM1	NM_001033.5	19	c.2308_2310del	p.Lys770del	conservative_inframe_deletion					
	LMO1(58.7%)	exon2,c.156C>G,p.A52=	0.587	0.246	25|33	6|1	0.53333	28|32	11	8251921	8251921	G	C	germline,normal_artifact,Germline	LMO1	NM_002315.3	2	c.156C>G	p.Ala52=	synonymous_variant				COSV59957325	
	MEN1(33.1%)	exon9,c.1269C>T,p.D423=	0.331	0.235	96|48	12|2	0.33333	102|51	11	64572602	64572602	G	A	germline,normal_artifact,Germline	MEN1	NM_000244.3	9	c.1269C>T	p.Asp423=	synonymous_variant	Benign		not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_1|Hyperparathyroidism		
-	ATM(12.1%)	exon6,c.497-8_497-4del	0.121	0.016	79|54	37|0	0.23938	197|62	11	108114661	108114666	ATTTTT	A	clustered_events,multiallelic	ATM	NM_000051.4	6	c.497-8_497-4del		splice_region_variant&intron_variant					
-	ATM(37.3%)	exon6,c.497-7_497-4del	0.373	0.016	79|179	37|0	0.53647	197|228	11	108114661	108114666	ATTTTT	AT	clustered_events,multiallelic	ATM	NM_000051.4	6	c.497-7_497-4del		splice_region_variant&intron_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
-	ATM(20.5%)	exon6,c.497-6_497-4del	0.205	0.016	79|91	37|0	0.40483	197|134	11	108114661	108114666	ATTTTT	ATT	clustered_events,multiallelic	ATM	NM_000051.4	6	c.497-6_497-4del		splice_region_variant&intron_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
-	ATM(4.8%)	exon6,c.497-5_497-4del	0.048	0.052	79|22	37|2	0.12444	197|28	11	108114661	108114666	ATTTTT	ATTT	clustered_events,multiallelic	ATM	NM_000051.4	6	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome		
-	ATM(5.5%)	exon6,c.497-4del	0.055	0.137	79|29	37|8	0.17917	197|43	11	108114661	108114666	ATTTTT	ATTTT	clustered_events,multiallelic,suspected_bg	ATM	NM_000051.4	6	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	ATM(3.0%)	exon6,c.497-4dup	0.03	0.102	79|17	37|6	0.09633	197|21	11	108114661	108114666	ATTTTT	ATTTTTT	clustered_events,multiallelic,suspected_bg	ATM	NM_000051.4	6	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Ataxia-telangiectasia_syndrome		
-	ATM(1.7%)	exon10,c.1236-9_1236-3del	0.017	0.014	60|14	33|0	0.06642	253|18	11	108121410	108121417	CTTTTTTT	C	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-9_1236-3del		splice_region_variant&intron_variant					
-	ATM(36.5%)	exon10,c.1236-8_1236-3del	0.365	0.014	60|220	33|0	0.49901	253|252	11	108121410	108121417	CTTTTTTT	CT	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-8_1236-3del		splice_region_variant&intron_variant					
-	ATM(5.0%)	exon10,c.1236-7_1236-3del	0.05	0.014	60|31	33|0	0.13356	253|39	11	108121410	108121417	CTTTTTTT	CTT	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-7_1236-3del		splice_region_variant&intron_variant					
-	ATM(6.4%)	exon10,c.1236-6_1236-3del	0.064	0.014	60|37	33|0	0.15385	253|46	11	108121410	108121417	CTTTTTTT	CTTT	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-6_1236-3del		splice_region_variant&intron_variant					
-	ATM(12.0%)	exon10,c.1236-5_1236-3del	0.12	0.044	60|68	33|2	0.28732	253|102	11	108121410	108121417	CTTTTTTT	CTTTT	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-5_1236-3del		splice_region_variant&intron_variant					
-	ATM(13.1%)	exon10,c.1236-4_1236-3del	0.131	0.067	60|69	33|4	0.28329	253|100	11	108121410	108121417	CTTTTTTT	CTTTTT	clustered_events,multiallelic	ATM	NM_000051.4	10	c.1236-4_1236-3del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast_and/or_ovarian_cancer		
-	ATM(3.1%)	exon10,c.1236-3dup	0.031	0.088	60|19	33|8	0.10601	253|30	11	108121410	108121417	CTTTTTTT	CTTTTTTTT	clustered_events,multiallelic,suspected_bg	ATM	NM_000051.4	10	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_neoplasm|Breast_and/or_ovarian_cancer		
	ATM(7.7%)	exon17,c.2577C>T,p.N859=	0.077	0.036	171|14	31|0	0.08531	193|18	11	108138008	108138008	C	T	PASS	ATM	NM_000051.4	17	c.2577C>T	p.Asn859=	synonymous_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|Ataxia-telangiectasia_syndrome|not_provided		
	ATM(1.1%)	exon45,c.6459A>G,p.K2153=	0.011	0.029	639|6	96|2	0.00772	771|6	11	108192034	108192034	A	G	normal_artifact	ATM	NM_000051.4	45	c.6459A>G	p.Lys2153=	synonymous_variant	Likely_benign		Ataxia-telangiectasia_syndrome		
	CEP164(18.1%)	exon5,c.345_347del,p.K116del	0.181	0.04	91|34	16|0	0.22930	121|36	11	117222647	117222650	GAAA	G	multiallelic	CEP164	NM_014956.5	5	c.345_347del	p.Lys116del	disruptive_inframe_deletion					
	CEP164(24.2%)	exon5,c.347del,p.K116fs	0.242	0.19	91|44	16|3	0.29651	121|51	11	117222647	117222650	GAAA	GAA	multiallelic,Germline	CEP164	NM_014956.5	5	c.347del	p.Lys116fs	frameshift_variant	Benign		not_provided|Nephronophthisis_15		
	CEP164(6.6%)	exon5,c.347dup,p.E117fs	0.066	0.141	91|14	16|2	0.06202	121|8	11	117222647	117222650	GAAA	GAAAA	multiallelic,suspected_bg	CEP164	NM_014956.5	5	c.347dup	p.Glu117fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Benign(1)	Nephronophthisis_15		
	CD3G(6.5%)	exon3,c.213del,p.K71fs	0.065	0.061	2386|173	368|25	0.06124	3449|225	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Pathogenic/Likely_pathogenic		Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
	CD3G(2.0%)	exon3,c.213dup,p.W72fs	0.02	0.019	2386|66	368|7	0.02350	3449|83	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic/Likely_pathogenic		Combined_immunodeficiency_due_to_CD3gamma_deficiency|Severe_combined_immunodeficiency_disease		
	KMT2A(2.3%)	exon3,c.2318del,p.P773fs	0.023	0.018	7149|233	1385|34	0.01912	14773|288	11	118344185	118344186	AC	A	normal_artifact,background	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Inborn_genetic_diseases|not_provided|Wiedemann-Steiner_syndrome		
	KMT2A(3.5%)	exon3,c.2629_2630del,p.D877fs	0.035	0.04	144|4	23|0	0.02395	163|4	11	118344493	118344495	TAG	T	slippage,suspected_bg	KMT2A	NM_001197104.2	3	c.2629_2630del	p.Asp877fs	frameshift_variant	Pathogenic		not_provided		
	KMT2A(3.0%)	exon33,c.11411T>C,p.V3804A	0.03	0.018	261|8	57|0	0.03300	293|10	11	118390761	118390761	T	C	PASS	KMT2A	NM_001197104.2	33	c.11411T>C	p.Val3804Ala	missense_variant					
	HSPA8(8.1%)	exon4,c.549C>T,p.Y183=	0.081	0.004498	1166|103	239|0	0.08049	1565|137	11	122930839	122930839	G	A	distinguished	HSPA8	NM_006597.6	4	c.549C>T	p.Tyr183=	synonymous_variant					
	KDM5A(1.0%)	exon19,c.2677C>T,p.R893*	0.009777	0.027	603|5	88|2	0.00732	678|5	12	427492	427492	G	A	normal_artifact	KDM5A	NM_001042603.3	19	c.2677C>T	p.Arg893*	stop_gained				COSV66991735	
	FGF6(83.1%)	exon1,c.189C>G,p.A63=	0.831	0.5	0|6	0|0	1.00000	0|6	12	4554548	4554548	G	C	germline	FGF6	NM_020996.3	1	c.189C>G	p.Ala63=	synonymous_variant				COSV57404741	
	CHD4(16.2%)	exon3,c.218del,p.K73fs	0.162	0.049	136|24	20|0	0.14208	157|26	12	6711545	6711546	CT	C	distinguished	CHD4	NM_001273.5	3	c.218del	p.Lys73fs	frameshift_variant					
	CHD4(47.7%)	exon2,c.13C>T,p.L5=	0.477	0.4	17|14	2|2	0.44444	20|16	12	6715527	6715527	G	A	germline,normal_artifact,Germline	CHD4	NM_001273.5	2	c.13C>T	p.Leu5=	synonymous_variant	Benign		not_provided		
	M6PR(1.3%)	exon4,c.422T>G,p.V141G	0.013	0.001827	3519|51	671|1	0.01312	5565|74	12	9096428	9096428	A	C	background	M6PR	NM_002355.4	4	c.422T>G	p.Val141Gly	missense_variant					
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0008798	0.002403	10121|9	3078|6	0.00170	29907|51	12	25378562	25378562	C	A	PASS	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(1)	not_provided|RASopathy		
1	KRAS(0.1%)	exon4,c.436G>A,p.A146T	0.001276	0.0004445	10121|14	3078|0	0.00067	29907|20	12	25378562	25378562	C	T	PASS	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(2)|Likely_pathogenic(1)|Uncertain_significance(2)	Neoplasm_of_the_large_intestine|RASopathy|OCULOECTODERMAL_SYNDROME,_SOMATIC|Cardiofaciocutaneous_syndrome_2|Encephalocraniocutaneous_lipomatosis|not_provided|Classic_Hodgkin_lymphoma		
1	KRAS(0.2%)	exon3,c.175G>A,p.A59T	0.001552	0.001925	7702|12	2019|3	0.00133	18020|24	12	25380283	25380283	C	T	normal_artifact	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic		
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.0008196	0.001165	7702|6	2019|2	0.00105	18020|19	12	25380283	25380283	C	A	normal_artifact	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided		
	KRAS(0.1%)	exon2,c.40G>A,p.V14I	0.001242	0.001367	10042|13	2482|2	0.00221	14930|33	12	25398279	25398279	C	T	low_allele_frac	KRAS	NM_033360.4	2	c.40G>A	p.Val14Ile	missense_variant	Pathogenic		Noonan_syndrome_3|Inborn_genetic_diseases|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Endometrial_carcinoma		
1	KRAS(30.4%)	exon2,c.35G>A,p.G12D	0.304	0.0005245	6913|2878	2474|0	0.29988	15939|6827	12	25398284	25398284	C	T	PASS	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Neoplasm_of_ovary|Cardiovascular_phenotype|Autoimmune_lymphoproliferative_syndrome_type_4|Non-small_cell_lung_carcinoma|Primary_low_grade_serous_adenocarcinoma_of_ovary|Vascular_Tumors_Including_Pyogenic_Granuloma|Thyroid_tumor|Congenital_Pulmonary_Airway_Malformations|not_provided|Encephalocraniocutaneous_lipomatosis|Juvenile_myelomonocytic_leukemia|Carcinoma_of_pancreas|Acute_myeloid_leukemia|RASopathy|Capillary_malformation-arteriovenous_malformation_1|Gastric_cancer|Epidermal_nevus|Lung_carcinoma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation		
	KMT2D(16.3%)	exon40,c.11580_11582del,p.Q3861del	0.163	0.143	31|5	6|0	0.17143	29|6	12	49426905	49426908	TTGC	T	slippage,distinguished	KMT2D	NM_003482.4	40	c.11580_11582del	p.Gln3861del	disruptive_inframe_deletion	Uncertain_significance		Kabuki_syndrome|KMT2D-related_disorder		
	KMT2D(25.2%)	exon40,c.11580G>A,p.Q3860=	0.252	0.284	30|9	6|0	0.22500	31|9	12	49426908	49426908	C	T	PASS	KMT2D	NM_003482.4	40	c.11580G>A	p.Gln3860=	synonymous_variant	Likely_benign		Kabuki_syndrome		
	KMT2D(96.9%)	exon40,c.10836G>A,p.Q3612=	0.969	0.75	0|35	0|2	1.00000	0|37	12	49427652	49427652	C	T	germline,normal_artifact,Germline	KMT2D	NM_003482.4	40	c.10836G>A	p.Gln3612=	synonymous_variant	Benign		Kabuki_syndrome_1|not_provided|not_specified|Kabuki_syndrome		
	KMT2D(3.3%)	exon32,c.7144C>A,p.P2382T	0.033	0.073	125|5	13|0	0.02370	206|5	12	49434409	49434409	G	T	distinguished	KMT2D	NM_003482.4	32	c.7144C>A	p.Pro2382Thr	missense_variant					
	KMT2D(0.2%)	exon11,c.2701T>C,p.S901P	0.001772	0.0009281	6630|20	1454|3	0.00949	15245|146	12	49444765	49444765	A	G	strand_bias,low_allele_frac	KMT2D	NM_003482.4	11	c.2701T>C	p.Ser901Pro	missense_variant					
	GLI1(38.5%)	exon8,c.821del,p.G274fs	0.385	0.216	44|30	12|2	0.38384	61|38	12	57860074	57860075	TG	T	germline,normal_artifact,distinguished	GLI1	NM_005269.3	8	c.821del	p.Gly274fs	frameshift_variant					
	FRS2(2.9%)	exon8,c.279T>C,p.R93=	0.029	0.013	688|21	96|0	0.02884	842|25	12	69965081	69965081	T	C	multiallelic	FRS2	NM_006654.5	8	c.279T>C	p.Arg93=	synonymous_variant					
	SELPLG(2.0%)	exon2,c.374A>C,p.Q125P	0.02	0.0085	1666|57	276|7	0.05996	3010|192	12	109017710	109017710	T	G	background	SELPLG	NM_003006.4	2	c.374A>C	p.Gln125Pro	missense_variant				COSV57315670	
-	HNF1A(4.3%)	exon4,c.872del,p.P291fs	0.043	0.127	118|8	11|2	0.05063	150|8	12	121432117	121432118	GC	G	multiallelic,slippage,background	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		not_provided|Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_3		
-	HNF1A(26.6%)	exon4,c.872dup,p.G292fs	0.266	0.062	118|46	11|0	0.27184	150|56	12	121432117	121432118	GC	GCC	multiallelic,slippage	HNF1A	NM_000545.8	4	c.872dup	p.Gly292fs	frameshift_variant	Pathogenic		not_provided|Diabetes_mellitus_type_1|Type_1_diabetes_mellitus_20|Maturity-onset_diabetes_of_the_young_type_3|Hepatic_adenomas,_familial|Maturity_onset_diabetes_mellitus_in_young|DiGeorge_syndrome|Clear_cell_carcinoma_of_kidney|Monogenic_diabetes		
	NCOR2(32.2%)	exon16,c.1529_1531del,p.Q510del	0.322	0.075	7|10	4|0	0.50000	12|12	12	124887058	124887064	GGCTGCT	GGCT	multiallelic,distinguished	NCOR2	NM_006312.6	16	c.1529_1531del	p.Gln510del	disruptive_inframe_deletion					
	POLE(6.1%)	exon34,c.4337_4338del,p.V1446fs	0.061	0.064	93|6	13|0	0.06087	108|7	12	133220098	133220100	CCA	C	slippage,distinguished	POLE	NM_006231.4	34	c.4337_4338del	p.Val1446fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Hereditary_cancer-predisposing_syndrome|not_provided		
	FLT1(17.4%)	exon2,c.130C>T,p.Q44*	0.174	0.046	158|36	27|0	0.16740	189|38	13	29041689	29041689	G	A	PASS	FLT1	NM_002019.4	2	c.130C>T	p.Gln44*	stop_gained					
-	BRCA2(2.4%)	exon10,c.1813del,p.I605fs	0.024	0.01	3612|100	666|11	0.02356	5803|140	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Gastric_cancer|not_provided|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Hereditary_breast_ovarian_cancer_syndrome|Fanconi_anemia_complementation_group_D1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2		
-	BRCA2(1.0%)	exon11,c.5073del,p.K1691fs	0.01	0.013	2806|37	476|7	0.00992	3994|40	13	32913558	32913559	CA	C	normal_artifact,suspected_bg	BRCA2	NM_000059.4	11	c.5073del	p.Lys1691fs	frameshift_variant	Pathogenic		not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome		
-	BRCA2(1.1%)	exon11,c.5351del,p.N1784fs	0.011	0.012	3346|42	534|8	0.01031	4897|51	13	32913836	32913837	CA	C	normal_artifact,suspected_bg	BRCA2	NM_000059.4	11	c.5351del	p.Asn1784fs	frameshift_variant	Pathogenic		Familial_cancer_of_breast|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_2		
-	BRCA2(1.1%)	exon23,c.9097del,p.T3033fs	0.011	0.008961	3054|42	517|4	0.00999	4856|49	13	32954022	32954023	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097del	p.Thr3033fs	frameshift_variant	Pathogenic		BRCA2-related_disorder|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Familial_cancer_of_breast		
-	BRCA2(2.4%)	exon23,c.9097dup,p.T3033fs	0.024	0.027	3054|83	517|16	0.02333	4856|116	13	32954022	32954023	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Gastric_cancer|Malignant_lymphoma,_large_B-cell,_diffuse|Hereditary_cancer-predisposing_syndrome|Neoplasm_of_ovary|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_breast_ovarian_cancer_syndrome|See_cases|not_provided|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_carcinoma|Breast_and/or_ovarian_cancer		
	NBEA(1.3%)	exon22,c.3362del,p.N1121fs	0.013	0.015	5341|85	890|16	0.01583	8578|138	13	35733662	35733663	TA	T	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
	NBEA(0.9%)	exon22,c.3362dup,p.N1121fs	0.009113	0.006968	5341|71	890|8	0.01164	8578|101	13	35733662	35733663	TA	TAA	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
-	RB1(3.3%)	exon7,c.608-4del	0.033	0.033	9183|381	2439|104	0.03508	28741|1045	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|RB1-related_disorder|Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_specified		
-	RB1(2.2%)	exon7,c.608-4dup	0.022	0.029	9183|256	2439|79	0.03405	28741|1013	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Retinoblastoma|RB1-related_disorder		
-	RB1(0.2%)	exon7,c.608-3C>T	0.002462	0.002225	10693|31	2862|6	0.00365	33599|123	13	48934150	48934150	C	T	normal_artifact,low_allele_frac	RB1	NM_000321.3	7	c.608-3C>T		splice_region_variant&intron_variant					
	EBPL(0.5%)	exon4,c.516T>A,p.F172L	0.004602	0.004162	2114|11	322|0	0.00522	2860|15	13	50235209	50235209	A	T	low_allele_frac	EBPL	NM_032565.5	4	c.516T>A	p.Phe172Leu	missense_variant					
	FGF14(10.9%)	exon5,c.714C>T,p.G238=	0.109	0.008629	622|78	124|0	0.10774	795|96	13	102375211	102375211	G	A	PASS	FGF14	NM_004115.4	5	c.714C>T	p.Gly238=	synonymous_variant					
	IRS2(88.8%)	exon1,c.2487C>T,p.P829=	0.888	0.5	0|8	0|0	1.00000	0|8	13	110435914	110435914	G	A	germline	IRS2	NM_003749.3	1	c.2487C>T	p.Pro829=	synonymous_variant	Benign		IRS2-related_disorder		
	DDHD1(50.0%)	exon1,c.354C>T,p.H118=	0.5	0.491	11|10	0|0	0.52174	11|12	14	53619463	53619463	G	A	germline	DDHD1	NM_001160148.2	1	c.354C>T	p.His118=	synonymous_variant	Benign		Hereditary_spastic_paraplegia_28|not_specified		
	DDHD1(49.7%)	exon1,c.331_336dup,p.G111_G112dup	0.497	0.68	10|8	0|1	0.47826	12|11	14	53619480	53619480	T	TGCCGCC	germline,normal_artifact	DDHD1	NM_001160148.2	1	c.331_336dup	p.Gly111_Gly112dup	conservative_inframe_insertion	Benign		Hereditary_spastic_paraplegia_28|not_provided		
	DDHD1(42.1%)	exon1,c.273C>T,p.F91=	0.421	0.5	13|10	1|1	0.46154	14|12	14	53619544	53619544	G	A	germline,normal_artifact,Germline	DDHD1	NM_001160148.2	1	c.273C>T	p.Phe91=	synonymous_variant	Benign		Hereditary_spastic_paraplegia_28|not_specified		
	RIN3(92.3%)	exon10,c.2913_2915del,p.G972del	0.923	0.667	0|15	0|1	1.00000	0|15	14	93154537	93154540	TGGC	T	germline,normal_artifact,Germline	RIN3	NM_024832.5	10	c.2913_2915del	p.Gly972del	disruptive_inframe_deletion					
2	HSP90AA1(2.4%)	exon12,c.2456-2A>T	0.024	0.026	353|8	51|0	0.01860	422|8	14	102548160	102548160	T	A	PASS	HSP90AA1	NM_001017963.3	12	c.2456-2A>T		splice_acceptor_variant&intron_variant					
	GOLGA6L4(92.9%)	exon6,c.1279G>A,p.D427N	0.929	0.667	0|15	0|1	1.00000	0|19	15	84909385	84909385	G	A	germline,normal_artifact,Germline	GOLGA6L4	NM_001267536.3	6	c.1279G>A	p.Asp427Asn	missense_variant				COSV65606843	
	NTRK3(29.1%)	exon17,c.1930C>T,p.P644S	0.291	0.024	178|70	46|0	0.28159	199|78	15	88472625	88472625	G	A	haplotype	NTRK3	NM_001012338.3	17	c.1930C>T	p.Pro644Ser	missense_variant					
	BLM(0.1%)	exon7,c.1497C>A,p.S499=	0.0009297	0.0007931	12302|16	3196|3	0.00264	36317|96	15	91304100	91304100	C	A	strand_bias,low_allele_frac	BLM	NM_000057.4	7	c.1497C>A	p.Ser499=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Bloom_syndrome		
	BLM(3.1%)	exon7,c.1544del,p.N515fs	0.031	0.022	13008|512	3527|111	0.03073	41693|1322	15	91304138	91304139	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		not_provided|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome|BLM-related_condition		
	BLM(1.9%)	exon7,c.1544dup,p.N515fs	0.019	0.019	13008|334	3527|84	0.02847	41693|1222	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,slippage,background	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Bloom_syndrome		
	BLM(2.1%)	exon18,c.3376del,p.I1126fs	0.021	0.017	335|7	69|0	0.02153	409|9	15	91346763	91346764	CA	C	PASS	BLM	NM_000057.4	18	c.3376del	p.Ile1126fs	frameshift_variant					
	CHD2(25.3%)	exon6,c.522del,p.V175*	0.253	0.132	40|12	7|0	0.24138	44|14	15	93480818	93480819	CA	C	slippage,distinguished	CHD2	NM_001271.4	6	c.522del	p.Val175*	frameshift_variant&stop_gained	Pathogenic/Likely_pathogenic		not_provided|Developmental_and_epileptic_encephalopathy_94		
	CHD2(39.4%)	exon29,c.3734del,p.K1245fs	0.394	0.042	598|417	166|9	0.37179	855|506	15	93540315	93540316	GA	G	multiallelic,normal_artifact,distinguished	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(4)|Uncertain_significance(1)|Benign(1)	History_of_neurodevelopmental_disorder|Developmental_and_epileptic_encephalopathy_94|not_provided|not_specified		
	CHD2(2.1%)	exon29,c.3734dup	0.021	0.019	598|27	166|4	0.04040	855|36	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Pathogenic/Likely_pathogenic		CHD2-related_disorder|Developmental_and_epileptic_encephalopathy_94		
	CHD2(4.3%)	exon33,c.4173dup,p.Q1392fs	0.043	0.067	304|13	54|3	0.03368	373|13	15	93545433	93545433	G	GA	normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Pathogenic		Complex_neurodevelopmental_disorder|Autistic_behavior|Seizure|Developmental_and_epileptic_encephalopathy_94|not_provided|CHD2-related_disorder		
	CHD2(1.2%)	exon39,c.5197C>T,p.P1733S	0.012	0.014	517|6	79|0	0.00990	600|6	15	93567645	93567645	C	T	PASS	CHD2	NM_001271.4	39	c.5197C>T	p.Pro1733Ser	missense_variant					
	IGF1R(4.3%)	exon10,c.2002del,p.I668fs	0.043	0.049	124|5	18|0	0.03797	152|6	15	99459902	99459903	CA	C	PASS	IGF1R	NM_000875.5	10	c.2002del	p.Ile668fs	frameshift_variant					
	TSC2(50.0%)	exon39,c.5028G>A,p.L1676=	0.5	0.333	10|9	1|0	0.47368	10|9	16	2137902	2137902	G	A	germline	TSC2	NM_000548.5	39	c.5028G>A	p.Leu1676=	synonymous_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Benign(8)|Likely_benign(6)	not_provided|Tuberous_sclerosis_syndrome|Hereditary_cancer-predisposing_syndrome|Tuberous_sclerosis_2|not_specified		
	TSC2(3.0%)	exon42,c.5334A>T,p.A1778=	0.03	0.05	145|4	26|0	0.03067	158|5	16	2138521	2138521	A	T	PASS	TSC2	NM_000548.5	42	c.5334A>T	p.Ala1778=	synonymous_variant					
	TSC2(5.5%)	exon42,c.5344G>A,p.A1782T	0.055	0.05	132|7	26|0	0.04487	149|7	16	2138531	2138531	G	A	haplotype,orientation	TSC2	NM_000548.5	42	c.5344G>A	p.Ala1782Thr	missense_variant	Uncertain_significance		Tuberous_sclerosis_2|Hereditary_cancer-predisposing_syndrome		
	CREBBP(58.4%)	exon30,c.5052C>T,p.S1684=	0.584	0.25	7|10	3|0	0.55556	8|10	16	3781313	3781313	G	A	germline,Germline	CREBBP	NM_004380.3	30	c.5052C>T	p.Ser1684=	synonymous_variant	Benign		not_specified|not_provided|Rubinstein-Taybi_syndrome|Inborn_genetic_diseases		
	CREBBP(53.8%)	exon7,c.1651C>A,p.L551I	0.538	0.667	7|7	0|2	0.50000	7|7	16	3831230	3831230	G	T	germline,normal_artifact	CREBBP	NM_004380.3	7	c.1651C>A	p.Leu551Ile	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Benign(6)	not_specified|Rubinstein-Taybi_syndrome|not_provided|Inborn_genetic_diseases		
	GRIN2A(5.0%)	exon13,c.4021del,p.S1341fs	0.05	0.07	161|8	24|2	0.03883	198|8	16	9857379	9857380	CT	C	normal_artifact,distinguished	GRIN2A	NM_001134407.3	13	c.4021del	p.Ser1341fs	frameshift_variant	Likely_pathogenic		not_provided		
	PALB2(1.2%)	exon4,c.886del,p.M296*	0.012	0.013	4975|68	1174|14	0.01077	10565|115	16	23646980	23646981	AT	A	normal_artifact,background	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Familial_cancer_of_breast|not_provided|Hereditary_cancer-predisposing_syndrome		
	CYLD(9.6%)	exon18,c.2371T>G,p.C791G	0.096	0.025	347|34	47|0	0.08686	410|39	16	50827477	50827477	T	G	PASS	CYLD	NM_015247.3	18	c.2371T>G	p.Cys791Gly	missense_variant					
	NUP93(1.1%)	exon19,c.2097del,p.F699fs	0.011	0.007185	2616|35	448|3	0.01111	4184|47	16	56872936	56872937	CT	C	suspected_bg	NUP93	NM_014669.5	19	c.2097del	p.Phe699fs	frameshift_variant					
	NUP93(0.3%)	exon19,c.2092T>C,p.F698L	0.003214	0.002709	2763|9	478|0	0.00261	4202|11	16	56872937	56872937	T	C	low_allele_frac	NUP93	NM_014669.5	19	c.2092T>C	p.Phe698Leu	missense_variant					
	CTCF(1.2%)	exon9,c.1662T>C,p.A554=	0.012	0.017	1310|18	191|2	0.01311	1656|22	16	67662416	67662416	T	C	background	CTCF	NM_006565.4	9	c.1662T>C	p.Ala554=	synonymous_variant					
-	CDH1(0.5%)	exon3,c.259del,p.R87fs	0.004556	0.002484	12642|90	3735|15	0.00526	35520|188	16	68835664	68835665	CA	C	normal_artifact,low_allele_frac	CDH1	NM_004360.5	3	c.259del	p.Arg87fs	frameshift_variant	Pathogenic		CDH1-related_diffuse_gastric_and_lobular_breast_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_diffuse_gastric_adenocarcinoma		
-	CDH1(1.0%)	exon4,c.504del,p.G169fs	0.01	0.008975	864|9	120|0	0.00977	1115|11	16	68842438	68842439	GA	G	suspected_bg	CDH1	NM_004360.5	4	c.504del	p.Gly169fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_diffuse_gastric_adenocarcinoma|CDH1-related_diffuse_gastric_and_lobular_breast_cancer_syndrome		
	PLCG2(2.0%)	exon3,c.302G>A,p.G101D	0.02	0.025	339|6	52|0	0.01442	410|6	16	81888157	81888157	G	A	PASS	PLCG2	NM_002661.5	3	c.302G>A	p.Gly101Asp	missense_variant				COSV63868152	
	FANCA(62.0%)	exon2,c.115A>C,p.R39=	0.62	0.5	8|12	1|2	0.60000	8|12	16	89882359	89882359	T	G	germline,normal_artifact	FANCA	NM_000135.4	2	c.115A>C	p.Arg39=	synonymous_variant	Benign/Likely_benign		Fanconi_anemia|not_specified|Fanconi_anemia_complementation_group_A		
	AURKB(0.8%)	exon6,c.475del,p.R159fs	0.007631	0.012	1272|10	233|2	0.00671	1924|13	17	8110129	8110130	CG	C	suspected_bg,low_allele_frac	AURKB	NM_004217.4	6	c.475del	p.Arg159fs	frameshift_variant					
-	NF1(1.8%)	exon2,c.61-4del	0.018	0.029	1061|23	156|4	0.01648	1373|23	17	29482988	29482989	CT	C	normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	2	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Cardiovascular_phenotype|Neurofibromatosis-Noonan_syndrome|not_provided|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis,_familial_spinal|Neurofibromatosis,_type_1|not_specified		
	CDK12(0.5%)	exon8,c.2669G>A,p.R890H	0.004782	0.023	1114|6	164|3	0.00445	1343|6	17	37667784	37667784	G	A	normal_artifact,low_allele_frac	CDK12	NM_016507.4	8	c.2669G>A	p.Arg890His	missense_variant&splice_region_variant				COSV71000029	
2	ERBB2(22.6%)	exon15,c.1738-3dup	0.226	0.02	131|43	43|0	0.18151	239|53	17	37873562	37873563	GC	GCC	multiallelic,slippage	ERBB2	NM_004448.4	15	c.1738-3dup		splice_acceptor_variant&intron_variant	Benign		not_provided		
2	ERBB2(3.0%)	exon15,c.1738-4_1738-3dup	0.03	0.02	131|6	43|0	0.04016	239|10	17	37873562	37873563	GC	GCCC	multiallelic,slippage,background	ERBB2	NM_004448.4	15	c.1738-4_1738-3dup		splice_acceptor_variant&intron_variant					
1	ERBB2(26.3%)	exon17,c.2033G>A,p.R678Q	0.263	0.009731	513|191	112|0	0.27571	641|244	17	37879658	37879658	G	A	PASS	ERBB2	NM_004448.4	17	c.2033G>A	p.Arg678Gln	missense_variant	Likely_pathogenic		Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Breast_neoplasm|Transitional_cell_carcinoma_of_the_bladder		
	KRTAP4-11(13.4%)	exon1,c.278_363delinsCTGTCGCCCCAGCTGCTGTGTGTCCAGCTGCTGCAGG,p.M93fs	0.134	0.155	104|17	21|3	0.17117	184|38	17	39274205	39274290	TCTGCAGCAGCTGGACACACAGCAGCTGGGGCGACAGCAGCTGGAGATGCAGCATCTGGGGCGGCAGCAAGTGGGCTGGCAGCACA	CCTGCAGCAGCTGGACACACAGCAGCTGGGGCGACAG	haplotype,orientation,background	KRTAP4-11	NM_033059.4	1	c.278_363delinsCTGTCGCCCCAGCTGCTGTGTGTCCAGCTGCTGCAGG	p.Met93fs	frameshift_variant&synonymous_variant				COSV66948020	
	XYLT2(29.2%)	exon8,c.1584del,p.G529fs	0.292	0.013	1272|512	313|9	0.26659	1967|715	17	48433966	48433967	AC	A	distinguished	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondylo-ocular_syndrome		
-	RNF43(2.1%)	exon9,c.1976del,p.G659fs	0.021	0.121	459|9	54|7	0.02226	615|14	17	56435160	56435161	AC	A	normal_artifact,suspected_bg	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		not_provided		
	RNF43(3.4%)	exon6,c.642G>A,p.L214=	0.034	0.077	156|4	15|0	0.02260	173|4	17	56439950	56439950	C	T	orientation	RNF43	NM_017763.6	6	c.642G>A	p.Leu214=	synonymous_variant					
2	PRKAR1A(1.4%)	exon9,c.770-2A>G	0.014	0.028	388|5	46|0	0.01101	449|5	17	66525009	66525009	A	G	PASS	PRKAR1A	NM_002734.5	9	c.770-2A>G		splice_acceptor_variant&intron_variant					
	SRSF2(97.3%)	exon1,c.144C>T,p.D48=	0.973	0.667	0|44	0|2	1.00000	0|51	17	74733099	74733099	G	A	germline,normal_artifact,Germline	SRSF2	NM_003016.4	1	c.144C>T	p.Asp48=	synonymous_variant	Benign		SRSF2-related_disorder		
	RPTOR(7.5%)	exon16,c.1693C>T,p.Q565*	0.075	0.111	44|4	8|0	0.07843	47|4	17	78857623	78857623	C	T	orientation	RPTOR	NM_020761.3	16	c.1693C>T	p.Gln565*	stop_gained					
	GATA6(10.5%)	exon7,c.1771G>A,p.A591T	0.105	0.12	43|4	8|0	0.08772	52|5	18	19780769	19780769	G	A	PASS	GATA6	NM_005257.6	7	c.1771G>A	p.Ala591Thr	missense_variant				COSV52526026	
	SETBP1(1.7%)	exon4,c.2681_2682del,p.F894*	0.017	0.01	689|12	133|0	0.01693	813|14	18	42531983	42531985	CTT	C	PASS	SETBP1	NM_015559.3	4	c.2681_2682del	p.Phe894*	frameshift_variant&stop_gained	Pathogenic		not_provided		
	BCL2(19.5%)	exon2,c.126C>T,p.A42=	0.195	0.2	23|5	3|0	0.17241	24|5	18	60985774	60985774	G	A	PASS	BCL2	NM_000633.3	2	c.126C>T	p.Ala42=	synonymous_variant					
	SMARCA4(10.6%)	exon8,c.1387G>A,p.E463K	0.106	0.043	138|16	22|0	0.10983	154|19	19	11101967	11101967	G	A	PASS	SMARCA4	NM_001128849.3	8	c.1387G>A	p.Glu463Lys	missense_variant	Uncertain_significance		Rhabdoid_tumor_predisposition_syndrome_2		
	NOTCH3(96.7%)	exon33,c.6668C>T,p.A2223V	0.967	0.667	0|36	0|1	1.00000	0|42	19	15271771	15271771	G	A	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	33	c.6668C>T	p.Ala2223Val	missense_variant	Benign		not_specified|not_provided|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1|Lateral_meningocele_syndrome		
	NOTCH3(83.3%)	exon25,c.4563A>G,p.P1521=	0.833	0.666	0|4	0|1	1.00000	0|4	19	15285052	15285052	T	C	germline,normal_artifact	NOTCH3	NM_000435.3	25	c.4563A>G	p.Pro1521=	synonymous_variant	Benign		Lateral_meningocele_syndrome|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1|not_specified|not_provided		
	NOTCH3(38.0%)	exon17,c.2742A>G,p.P914=	0.38	0.25	21|13	5|1	0.35000	26|14	19	15292437	15292437	T	C	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	17	c.2742A>G	p.Pro914=	synonymous_variant	Benign		not_provided|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1|Lateral_meningocele_syndrome|not_specified		
	NOTCH3(51.4%)	exon16,c.2538C>T,p.C846=	0.514	0.744	12|15	0|3	0.56667	13|17	19	15295134	15295134	G	A	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	16	c.2538C>T	p.Cys846=	synonymous_variant	Benign		Lateral_meningocele_syndrome|not_specified|not_provided|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1		
	NOTCH3(50.3%)	exon3,c.303C>T,p.T101=	0.503	0.463	27|28	5|3	0.50877	28|29	19	15303225	15303225	G	A	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	3	c.303C>T	p.Thr101=	synonymous_variant	Benign		not_specified|not_provided|Lateral_meningocele_syndrome|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1		
	BRD4(6.6%)	exon5,c.766del,p.Q256fs	0.066	0.071	69|4	12|0	0.04598	83|4	19	15376247	15376248	TG	T	distinguished	BRD4	NM_058243.3	5	c.766del	p.Gln256fs	frameshift_variant					
	JAK3(6.0%)	exon2,c.115del,p.Q39fs	0.06	0.068	153|9	13|0	0.05085	168|9	19	17955111	17955112	TG	T	distinguished	JAK3	NM_000215.4	2	c.115del	p.Gln39fs	frameshift_variant	Pathogenic		not_provided|T-B+_severe_combined_immunodeficiency_due_to_JAK3_deficiency		
	PIK3R2(94.1%)	exon8,c.937T>C,p.S313P	0.941	0.667	0|19	0|1	1.00000	0|24	19	18273047	18273047	T	C	germline,normal_artifact,Germline	PIK3R2	NM_005027.4	8	c.937T>C	p.Ser313Pro	missense_variant	Benign		not_specified|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus_syndrome_1		
	FCGBP(36.2%)	exon29,c.13098A>G,p.P4366=	0.362	0.248	64|41	10|3	0.36441	75|43	19	40367862	40367862	T	C	germline,normal_artifact,Germline	FCGBP	NM_003890.2	29	c.13098A>G	p.Pro4366=	synonymous_variant				COSV55426346	
	AXL(30.3%)	exon20,c.2588C>T,p.A863V	0.303	0.027	119|55	37|0	0.29954	152|65	19	41765712	41765712	C	T	PASS	AXL	NM_021913.5	20	c.2588C>T	p.Ala863Val	missense_variant					
	CIC(46.1%)	exon10,c.2292G>A,p.L764=	0.461	0.75	8|7	0|2	0.46667	8|7	19	42795212	42795212	G	A	germline,normal_artifact	CIC	NM_015125.5	10	c.2292G>A	p.Leu764=	synonymous_variant					
	BICRA(7.8%)	exon8,c.2810dup,p.P938fs	0.078	0.083	68|5	8|0	0.04950	96|5	19	48197890	48197891	AC	ACC	multiallelic,slippage,distinguished	BICRA	NM_015711.3	8	c.2810dup	p.Pro938fs	frameshift_variant					
	BAX(3.1%)	exon3,c.121del,p.E41fs	0.031	0.012	1745|76	248|5	0.03148	2923|95	19	49458970	49458971	TG	T	multiallelic,normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon		
	POLD1(50.0%)	exon9,c.1036del,p.E346fs	0.5	0.334	4|4	2|0	0.50000	4|4	19	50906369	50906370	TG	T	PASS	POLD1	NM_002691.4	9	c.1036del	p.Glu346fs	frameshift_variant					
	SSTR4(18.4%)	exon1,c.883G>A,p.V295M	0.184	0.007214	941|207	174|0	0.18207	1168|260	20	23017003	23017003	G	A	chemotherapy_site	SSTR4	NM_001052.4	1	c.883G>A	p.Val295Met	missense_variant				COSV99658514	
-	ASXL1(26.4%)	exon13,c.1934del,p.G645fs	0.264	0.25	16|6	2|0	0.25000	21|7	20	31022441	31022442	AG	A	slippage	ASXL1	NM_015338.6	13	c.1934del	p.Gly645fs	frameshift_variant					
	ASXL1(5.7%)	exon13,c.2975T>C,p.L992P	0.057	0.058	73|4	16|0	0.04494	85|4	20	31023490	31023490	T	C	PASS	ASXL1	NM_015338.6	13	c.2975T>C	p.Leu992Pro	missense_variant					
	SRC(85.7%)	exon12,c.1218G>C,p.A406=	0.857	0.8	0|6	0|3	1.00000	0|6	20	36030939	36030939	G	C	germline,normal_artifact	SRC	NM_198291.3	12	c.1218G>C	p.Ala406=	synonymous_variant				COSV62440282	
	ADNP(2.5%)	exon5,c.3047dup,p.A1017fs	0.025	0.023	8204|264	1943|60	0.02830	18953|552	20	49508203	49508204	CT	CTT	multiallelic,normal_artifact,suspected_bg	ADNP	NM_015339.5	5	c.3047dup	p.Ala1017fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|ADNP-related_multiple_congenital_anomalies_-_intellectual_disability_-_autism_spectrum_disorder		
	C21orf58(20.0%)	exon8,c.894_896del,p.H299del	0.2	0.143	50|10	7|0	0.19178	59|14	21	47721985	47721988	ATGG	A	slippage,distinguished	C21orf58	NM_058180.5	8	c.894_896del	p.His299del	disruptive_inframe_deletion					
	CRKL(2.4%)	exon2,c.675A>G,p.A225=	0.024	0.00473	1608|37	269|0	0.01974	2135|43	22	21288430	21288430	A	G	PASS	CRKL	NM_005207.4	2	c.675A>G	p.Ala225=	synonymous_variant					
	CHEK2(0.1%)	exon2,c.266C>T,p.T89I	0.001196	0.0007999	12082|17	3257|2	0.00080	40163|32	22	29130444	29130444	G	A	low_allele_frac	CHEK2	NM_007194.4	2	c.266C>T	p.Thr89Ile	missense_variant	Uncertain_significance		Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome		
-	NF2(1.1%)	exon12,c.1160del,p.K387fs	0.011	0.018	515|6	70|0	0.00984	604|6	22	30069291	30069292	GA	G	PASS	NF2	NM_000268.4	12	c.1160del	p.Lys387fs	frameshift_variant					
-	NF2(8.1%)	exon15,c.1737+4C>T	0.081	0.126	41|4	10|0	0.08163	45|4	22	30077594	30077594	C	T	PASS	NF2	NM_000268.4	15	c.1737+4C>T		splice_region_variant&intron_variant					
	SOX10(83.3%)	exon4,c.927T>C,p.H309=	0.833	0.75	0|4	0|2	1.00000	0|4	22	38369976	38369976	A	G	germline,normal_artifact	SOX10	NM_006941.4	4	c.927T>C	p.His309=	synonymous_variant	Benign		Waardenburg_syndrome|not_specified|not_provided|Waardenburg_syndrome_type_2E|PCWH_syndrome|Waardenburg_syndrome_type_4C		
	SOX10(55.7%)	exon4,c.782G>A,p.R261H	0.557	0.25	4|4	2|0	0.50000	5|5	22	38370121	38370121	C	T	PASS	SOX10	NM_006941.4	4	c.782G>A	p.Arg261His	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Likely_benign(1)	not_provided		
	CYP2D6(15.5%)	exon7,c.1117G>A,p.G373S	0.155	0.093	342|54	50|3	0.15856	398|75	22	42523505	42523505	C	T	haplotype,normal_artifact,chemotherapy_site	CYP2D6	NM_000106.6	7	c.1117G>A	p.Gly373Ser	missense_variant	drug_response		Tramadol_response		
	CYP2D6(15.2%)	exon7,c.1108G>A,p.V370I	0.152	0.093	339|52	50|3	0.14570	387|66	22	42523514	42523514	C	T	haplotype,normal_artifact,chemotherapy_site	CYP2D6	NM_000106.6	7	c.1108G>A	p.Val370Ile	missense_variant				COSV62243101	
	CYP2D6(10.2%)	exon7,c.1083T>C,p.H361=	0.102	0.049	331|28	49|1	0.09501	381|40	22	42523539	42523539	A	G	normal_artifact,strand_bias,chemotherapy_site	CYP2D6	NM_000106.6	7	c.1083T>C	p.His361=	synonymous_variant				COSV62243713	
	CYP2D6(5.2%)	exon7,c.1064A>G,p.Y355C	0.052	0.05	335|13	48|1	0.05839	387|24	22	42523558	42523558	T	C	normal_artifact,strand_bias,chemotherapy_site	CYP2D6	NM_000106.6	7	c.1064A>G	p.Tyr355Cys	missense_variant	Likely_benign		not_provided		
-	BCOR(8.6%)	exon9,c.4093del,p.T1365fs	0.086	0.1	51|4	11|0	0.06667	56|4	X	39922078	39922079	GT	G	PASS	BCOR	NM_001123385.2	9	c.4093del	p.Thr1365fs	frameshift_variant					
-	BCOR(18.4%)	exon4,c.2514del,p.K839fs	0.184	0.049	114|23	20|0	0.15758	139|26	X	39932084	39932085	TG	T	PASS	BCOR	NM_001123385.2	4	c.2514del	p.Lys839fs	frameshift_variant	Pathogenic		Oculofaciocardiodental_syndrome		
	BCOR(31.2%)	exon4,c.1260T>C,p.D420=	0.312	0.27	59|29	9|2	0.29897	68|29	X	39933339	39933339	A	G	germline,normal_artifact,Germline	BCOR	NM_001123385.2	4	c.1260T>C	p.Asp420=	synonymous_variant	Benign		not_specified|not_provided|Inborn_genetic_diseases|Oculofaciocardiodental_syndrome		
	ARAF(6.9%)	exon6,c.547del,p.Q183fs	0.069	0.04	125|10	23|0	0.07229	154|12	X	47424733	47424734	AC	A	PASS	ARAF	NM_001654.5	6	c.547del	p.Gln183fs	frameshift_variant					
	AMER1(14.3%)	exon2,c.916G>T,p.G306W	0.143	0.023	198|37	48|0	0.15354	215|39	X	63412251	63412251	C	A	PASS	AMER1	NM_152424.4	2	c.916G>T	p.Gly306Trp	missense_variant					
	AR(43.0%)	exon1,c.231_239del,p.Q78_Q80del	0.43	0.194	0|7	0|0	0.47059	9|8	X	66765158	66765170	TGCAGCAGCAGCA	TGCA	germline,multiallelic	AR	NM_000044.6	1	c.231_239del	p.Gln78_Gln80del	disruptive_inframe_deletion	Benign/Likely_benign		not_specified|not_provided|Androgen_resistance_syndrome|Kennedy_disease		
	MED12(33.4%)	exon22,c.3180C>T,p.H1060=	0.334	0.041	68|36	26|0	0.32773	80|39	X	70347941	70347941	C	T	PASS	MED12	NM_005120.3	22	c.3180C>T	p.His1060=	synonymous_variant					
	MED12(4.5%)	exon43,c.6306_6308del,p.Q2103del	0.045	0.067	97|6	13|0	0.04082	188|8	X	70361097	70361100	ACAG	A	slippage,suspected_bg	MED12	NM_005120.3	43	c.6306_6308del	p.Gln2103del	disruptive_inframe_deletion	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Likely_benign(2)	FG_syndrome|MED12-related_disorder|Familial_thoracic_aortic_aneurysm_and_aortic_dissection		
	TAF1(15.9%)	exon22,c.3288T>C,p.S1096=	0.159	0.084	45|9	15|0	0.16364	46|9	X	70613977	70613977	T	C	PASS	TAF1	NM_004606.5	22	c.3288T>C	p.Ser1096=	synonymous_variant					
	ATRX(1.3%)	exon17,c.4796G>A,p.G1599D	0.013	0.022	390|6	59|0	0.01255	472|6	X	76890098	76890098	C	T	PASS	ATRX	NM_000489.6	17	c.4796G>A	p.Gly1599Asp	missense_variant					
-	ATRX(13.2%)	exon9,c.1960C>T,p.R654*	0.132	0.021	287|43	59|0	0.12465	316|45	X	76938788	76938788	G	A	PASS	ATRX	NM_000489.6	9	c.1960C>T	p.Arg654*	stop_gained	Pathogenic		Alpha_thalassemia-X-linked_intellectual_disability_syndrome		
	STAG2(12.3%)	exon12,c.1079T>C,p.L360P	0.123	0.009445	428|63	103|0	0.12029	607|83	X	123185032	123185032	T	C	PASS	STAG2	NM_001042749.2	12	c.1079T>C	p.Leu360Pro	missense_variant					
-	STAG2(1.0%)	exon20,c.1840C>T,p.R614*	0.009963	0.0085	840|9	156|0	0.01070	1017|11	X	123197716	123197716	C	T	background	STAG2	NM_001042749.2	20	c.1840C>T	p.Arg614*	stop_gained				COSV54351398	
	BCORL1(11.2%)	exon4,c.1340A>G,p.Q447R	0.112	0.029	160|20	42|0	0.10660	176|21	X	129148088	129148088	A	G	PASS	BCORL1	NM_021946.5	4	c.1340A>G	p.Gln447Arg	missense_variant					
